please go through our product list
Sr. | Brand Name | Composition | Ph. | Strength | Category | |
No. | Ref | |||||
1 | Methylprednisolone Tablet IP | Each Film Coated Tablet Contains: | glucocorticoids | |||
Methylprednisolone | IP | 16 mg | ||||
Excipients | q. s. | |||||
2 | Methylprednisolone Tablet IP | Each Film Coated Tablet Contains: | glucocorticoids | |||
Methylprednisolone | IP | 4 mg | ||||
Excipients | q. s. | |||||
3 | Atorvastatin Tablets IP | Each Film Coated Tablet Contains: | ||||
Atorvastatin Calcium | IP | 20 mg | HMG-CoA reductase inhibitors (statins) | |||
eq. to Atorvastatin | ||||||
Excipients | q. s. | |||||
4 | Amlodipine Besylate & Atenolol Tablets | Each Uncoated Tablet Contains: | ||||
Amlodipine Besylate | beta blockers | |||||
Eq. to Amlodipine | IP | 5 mg | ||||
Atenolol | IP | 50 mg | ||||
Excipients | q. s. | |||||
5 | Calcium and vitamin D3 Tablets IP | Each Film Coated Tablet Contains: | ||||
Calcium Carbonate (from an organic source oyster shell | Food supplement | |||||
Eq. to elemental calcium | IP | 500 mg | ||||
Vitamin D3 | IP | 250 IU | ||||
Excipients | q. s. | |||||
6 | Cetrizine Dihydrochloride Tablets IP | Each Film Coated Tablet Contains: | ||||
Cetrizine Dihydrochloride | IP | 10 mg | antihistamines | |||
Excipients | q. s. | |||||
7 | Deflazacort Tablets | Each Uncoated Tablet Contains: | corticosteroids | |||
Deflazacort | IP | 6 mg | ||||
Excipients | q. s. | |||||
8 | Methylprednisolone Tablet IP | Each Film Coated Tablet Contains: | glucocorticoids | |||
Methylprednisolone | IP | 8 mg | ||||
Excipients | q. s. | |||||
9 | Ranitidine Tablet | Each Film Coated Tablet Contains: | H2 antagonist | |||
Ranitidine Hydrochloride | ||||||
Eq. to Ranitidine | IP | 150 mg | ||||
Excipients | q. s. | |||||
10 | Ofloxacin & Ornidazole Tablets | Each Film Coated Tablet Contains: | antibiotics | |||
Ofloxacin | IP | 200 mg | ||||
Ornidazole | IP | 500 mg | ||||
Excipients | q. s. | |||||
11 | Ciprofloxacin Tablets | Each Film Coated Tablet Contains: | quinolone antibiotics | |||
Ciprofloxacin hydrochloride | ||||||
Eq. to Ciprofloxacin | IP | 250 mg | ||||
Excipients | q. s. | |||||
12 | Ofloxacin Tablets | Each Film Coated Tablet Contains: | antibiotics | |||
Ofloxacin | IP | 400 mg | ||||
Excipients | q. s. | |||||
13 | Fluconazole Tablets | Each Uncoated Tablet Contains: | antifungal | |||
Fluconazole | IP | 150 mg | ||||
Excipients | q. s. | |||||
14 | Sildenafil Citrate 50 mg Tablets | Each Film Coated Tablet Contains: | erectile dysfunction | |||
Sildenafil Citrate | IP | 50 mg | ||||
Excipients | q. s. | |||||
15 | Sildenafil Citrate 100 mg Tablets | Each Film Coated Tablet Contains: | erectile dysfunction | |||
Sildenafil Citrate | IP | 100 mg | ||||
Excipients | q. s. | |||||
16 | Methylprednisolone Tablet IP | Each Uncoated Tablet Contains: | glucocorticoids | |||
Methylprednisolone | IP | 4 mg | ||||
Excipients | q. s. | |||||
17 | Ursodeoxycholic Acid Tablets IP 150 mg | Each Uncoated Tablet Contains: | cholestero gallstone | |||
Ursodeoxycholic Acid | IP | 150 mg | ||||
Excipients | q. s. | |||||
18 | Ursodeoxycholic Acid Tablets IP 300 mg | Each Uncoated Tablet Contains: | ||||
Ursodeoxycholic Acid | IP | 300 mg | cholestero gallstone | |||
Excipients | q. s. | |||||
19 | Ursodeoxycholic Acid Sustained releaseTablets 500 mg | Each Filmcoated Tablet Contains: | ||||
Ursodeoxycholic Acid | BP | 500 mg | cholestero gallstone | |||
Excipients | q. s. | |||||
20 | Pantaprazole Tablets IP 40 mg | Each enteric Coated Tablet contains: | ||||
Pantaprazole Sodium Sesquihydrate | IP | 40 mg | Proton-pump inhibitor | |||
Eq. to Pantaprazole | ||||||
Excipients | q. s. | |||||
21 | Citicolin Tablets IP 500 mg | Each Film Coated Tablet Contains: | Nootropic | |||
Citicoline (as Sodium) | ||||||
Eq. to Citicoline | IP | 500 mg | ||||
Excipients | q. s. | |||||
Cetirizine Dihydrochoride,Phenylepherine.HCL & | Each Uncoated Tablet Contains: | |||||
Cetrizine Dihydrochloride | IP | 5mg | ||||
Phenylephrine HCl | IP | 10mg | Anti histamine | |||
22 | Paracetamol | IP | 325mg | |||
Excipients | ||||||
23 | Tizanidine Hcl Tablets IP | Each Uncoated Tablet Contains: | ||||
Tizanidine HCl | IP | 2 mg | alpha-2-adrenergic agonists | |||
Excipients | q. s. | |||||
24 | Levetiracetam Tablets IP | Each Film Coated Tablet Contains: | ||||
Levetiracetam | IP | 500 mg | anticonvulsants | |||
Excipients | q. s. | |||||
25 | Levetiracetam Tablets IP | Each Film Coated Tablet Contains: | ||||
Levetiracetam | IP | 750 mg | ||||
Excipients | q. s. | anticonvulsants | ||||
26 | Ketorolac Tromethamine Tablets IP | Each Uncoated Tablet Contains: | ||||
Ketorolac Tromethamine | IP | 10 mg | ||||
Excipients | q. s. | |||||
27 | Domperidone Tablets IP | Each Uncoated Tablet Contains: | ||||
Domperidone Maleate | anti-inflammatory | |||||
Eq. to Domperidone | IP | 10 mg | ||||
Excipients | q. s. | |||||
28 | Serratiopeptidase Tablets IP | Each Film Coated Tablet Contains: | ||||
Serratiopeptidase (Enzyme Activity-2000 unit) | IP | 10 mg | antibiotics | |||
Excipients | q. s. | |||||
29 | Voriconazole Tablet IP | Each Film Coated Tablet Contains: | ||||
Voriconazole | IP | 200 mg | ||||
Excipients | q. s. | |||||
30 | Aciclovir Tablets IP | Each Uncoated Tablet Contains: | ||||
Aciclovir | IP | 400 mg | antiviral | |||
Excipients | q. s. | |||||
31 | Rosuvastatin & Fenofibrate Tablet IP | Each Film Coated Tablet Contains: | ||||
Rosuvastatin Calcium | Lipid-Lowering Agents, Statin | |||||
Eq. to Rosuvastatin | IP | 10 mg | ||||
Fenofibrate (micronized) | IP | 160 mg | ||||
Excipients | q. s. | |||||
32 | Nicorandil Tablets IP | Each Prolonged Release Tablet Contains: | ||||
Nicorandil | IP | 20 mg | potassium channel activators | |||
Excipients | q. s. | |||||
33 | Nicorandil Tablets IP | Each Prolonged Release Tablet Contains: | ||||
Nicorandil | IP | 10 mg | potassium channel activators | |||
Excipients | q. s. | |||||
34 | Nicorandil Tablets IP | Each Prolonged Release Tablet Contains: | ||||
Nicorandil | IP | 5 mg | potassium channel activators | |||
Excipients | q. s. | |||||
35 | Ondansertron Tablets IP | Each Uncoated Tablet Contains: | ||||
Ondansertron Hcl | 5-HT3 receptor antagonists | |||||
Eq. to Ondansertron | IP | 8 mg | ||||
Excipients | q. s. | |||||
36 | Hydroxyzine Hcl Tablets IP | Each Uncoated Tablet Contains: | antihistamines | |||
Hydroxyzine Hcl | IP | 10 mg | ||||
Excipients | q. s. | |||||
37 | Hydroxyzine Hcl Tablets IP | Each Uncoated Tablet Contains: | ||||
Hydroxyzine Hcl | IP | 25 mg | antihistamines | |||
Excipients | q. s. | |||||
38 | Tranexamic Acid Tablets IP | Each Film Coated Tablet Contains: | ||||
Tranexamic Acid | IP | 500 mg | antifibrinolytics | |||
Excipients | q. s. | |||||
39 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains: | ||||
Levofloxacin hemi-hydrate | antibiotics | |||||
Eq. to Levofloxacin | IP | 250 mg | ||||
Excipients | q. s. | |||||
40 | Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains: | bacterial infections. | |||
Ciprofloxacin hydrochloride | ||||||
Eq. to Ciprofloxacin | IP | 500 mg | ||||
Excipients | q. s. | |||||
41 | Roxithromycin Tablets IP | Each Film Coated Tablet Contains: | macrolides | |||
Roxithromycin | IP | 150 mg | ||||
Excipients | q. s. | |||||
42 | Ramipril Tablets IP | Each Film Coated Tablet Contains: | ||||
Ramipril | IP | 10 mg | (ACE) inhibitors. | |||
Excipients | q. s. | |||||
43 | Ramipril Tablets IP | Each Film Coated Tablet Contains: | ||||
Ramipril | IP | 5 mg | (ACE) inhibitors. | |||
Excipients | q. s. | |||||
44 | Ramipril Tablets IP | Each Film Coated Tablet Contains: | ||||
Ramipril | IP | 2.5 mg | (ACE) inhibitors. | |||
Excipients | q. s. | |||||
45 | Mefenamic Acid & Dicyclomine hydrochloride Tablets IP | Each Uncoated Tablet Contains: | ||||
Mefenamic Acid | IP | 250 mg | ||||
Dicyclomine Hcl | IP | 10 mg | Anti-inflammatory, analgesic | |||
Excipients | q. s. | |||||
46 | Torsemide Tablets IP | Each Uncoated Tablet Contains: | diuretics | |||
Torsemide | IP | 20 mg | ||||
Excipients | q. s. | |||||
47 | Olmesartan Medoxomil Tablets IP 20mg | Each Film Coated Tablet Contains: | (hypertension). | |||
Olmesartan Medoxmil | IP | 20mg | ||||
Excipients | q. s. | |||||
48 | Olmesartan Medoxomil Tablets IP 40mg | Each Film Coated Tablet Contains: | (hypertension). | |||
Olmesartan Medoxmil | IP | 40mg | ||||
Excipients | q. s. | |||||
49 | Olmesartan Medoxomil & Hydrochlothiazide Tablets IP | Each Film Coated Tablet Contains: | (hypertension). | |||
Olmesartan Medoxmil | IP | 20 mg | ||||
Hydrochlothiazide | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
50 | Olmesartan Medoxomil & Hydrochlothiazide Tablets IP | Each Film Coated Tablet Contains: | (hypertension). | |||
Olmesartan Medoxmil | IP | 40 mg | ||||
Hydrochlothiazide | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
51 | Olmesartan Medoxomil & Amlodipine Tablets | Each Film Coated Tablet Contains: | (hypertension). | |||
Olmesartan Medoxmil | IP | 20 mg | ||||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
52 | Olmesartan Medoxomil & Metoprolol Succinate (Extended Release) Tablets | Each Uncoated bilayered Tablet Contains: | (hypertension). | |||
Olmesartan Medoxomil | IP | 20 mg | ||||
Metoprolol Succinate | ||||||
Eq. to Metoprolol Tartrate | IP | 50 mg | ||||
(As extended release) | ||||||
Excipients | q. s. | |||||
53 | Rosuvastatin & Fenofibrate Tablet IP | Each Film Coated Tablet Contains: | ||||
Rosuvastatin Calcium | ||||||
Eq. to Rosuvastatin | IP | 5 mg | statins | |||
Fenofibrate (micronized) | IP | 160 mg | ||||
Excipients | q. s. | |||||
54 | Gliclazide Tablets IP | Each Uncoated Tablet Contains: | ||||
Gliclazide | IP | 80 mg | ||||
Excipients | q. s. | |||||
55 | Gliclazide & Metformin hydrochloride Tablets | Each Uncoated Tablet Contains: | sulfonylurea. | |||
Gliclazide | IP | 80 mg | ||||
Metformin hydrochloride | IP | 500 mg | ||||
Excipients | q. s. | |||||
56 | Cholecalciferol chewable tablet 60,000IU | Each Uncoated chewable Tablet Contains: | vitamin D analogs. | |||
Cholecalciferol | IP | 60,000 IU | ||||
Excipients | q. s. | |||||
57 | Pregabalin & Nortriptyline Tablets | Each Film Coated Tablet Contains: | antidepressants. | |||
Pregabalin | IP | 75 mg | ||||
Nortriptyline hydrochloride | ||||||
Eq. to Nortriptyline | IP | 10 mg | ||||
Excipients | q. s. | |||||
58 | Rosuvastatin Tablet IP 40 mg | Each Film Coated Tablet Contains: | Statin | |||
Rosuvastatin Calcium | ||||||
Eq. to Rosuvastatin | IP | 40 mg | ||||
Excipients | q. s. | |||||
59 | Rosuvastatin Tablet IP 5 mg | Each Film Coated Tablet Contains: | Statin | |||
Rosuvastatin Calcium | ||||||
Eq. to Rosuvastatin | IP | 5 mg | ||||
Excipients | q. s. | |||||
60 | Rosuvastatin Tablet IP 10 mg | Each Film Coated Tablet Contains: | Statin | |||
Rosuvastatin Calcium | ||||||
Eq. to Rosuvastatin | IP | 10 mg | ||||
Excipients | q. s. | |||||
61 | Rosuvastatin Tablet IP 20 mg | Each Film Coated Tablet Contains: | Statin | |||
Rosuvastatin Calcium | ||||||
Eq. to Rosuvastatin | IP | 20 mg | ||||
Excipients | q. s. | |||||
62 | Talmisartan Tablets IP 20 mg | Each Uncoated Tablet Contains: | hypertension | |||
Telmisartan | IP | 20 mg | ||||
Excipients | q. s. | |||||
63 | Talmisartan Tablets IP 40 mg | Each Uncoated Tablet Contains: | hypertension | |||
Telmisartan | IP | 40 mg | ||||
Excipients | q. s. | |||||
64 | Talmisartan Tablets IP 80 mg | Each Uncoated Tablet Contains: | hypertension | |||
Telmisartan | IP | 80 mg | ||||
Excipients | q. s. | |||||
65 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayeredTablet Contains: | hypertension | |||
Telmisartan | IP | 40 mg | ||||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
66 | Telmisartan &Hydrochlorthiazide Tablets IP | Each Uncoated Tablet Contains: | hypertension | |||
Telmisartan | IP | 40 mg | ||||
Hydrochlothiazide | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
67 | Pantoprazole Gastro-resistant Tablets IP 40 mg | Each Gastro-resistant Tablets Contains: | Proton-pump inhibitor | |||
Pantaprazole Sodium Sesquihydrate | ||||||
Eq. to Pantoprazole | IP | 40 mg | ||||
Excipients | q. s. | |||||
68 | Glimepiride Tablets IP 1 mg | Each Uncoated Tablet Contains: | sulfonylureas | |||
Glimepiride | IP | 1 mg | ||||
Excipients | q. s. | |||||
69 | Glimepiride Tablets IP 2 mg | Each Uncoated Tablet Contains: | sulfonylureas | |||
Glimepiride | IP | 2 mg | ||||
Excipients | q. s. | |||||
70 | Glimepiride Tablets IP 3 mg | Each Uncoated Tablet Contains: | sulfonylureas | |||
Glimepiride | IP | 3 mg | ||||
Excipients | q. s. | |||||
71 | Glimepiride Tablets IP 4 mg | Each Uncoated Tablet Contains: | sulfonylureas | |||
Glimepiride | IP | 4 mg | ||||
Excipients | q. s. | |||||
72 | Cilnidipine Tablets IP 5 mg | Each Film Coated Tablet Contains: | ||||
Cilnidipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
73 | Cilnidipine Tablets IP 10 mg | Each Film Coated Tablet Contains: | calcium channel blocker | |||
Cilnidipine | IP | 10 mg | ||||
Excipients | q. s. | |||||
74 | Cilnidipine Tablets IP 20 mg | Each Film Coated Tablet Contains: | calcium channel blocker | |||
Cilnidipine | IP | 20 mg | ||||
Excipients | q. s. | |||||
75 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | antidiabetic | |||
Vildagliptin | IP | 50 mg | ||||
Metformin Hydrochloride | IP | 500 mg | ||||
Excipients | q. s. | |||||
76 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | antidiabetic | |||
Vildagliptin | IP | 50 mg | ||||
Metformin Hydrochloride | IP | 850 mg | ||||
Excipients | q. s. | |||||
77 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | antidiabetic | |||
Vildagliptin | IP | 50 mg | ||||
Metformin Hydrochloride | IP | 1000 mg | ||||
Excipients | q. s. | |||||
78 | Atorvastatin Tablets IP 80 mg | Each Film Coated Tablet Contains: | statins. | |||
Atorvastatin Calcium | IP | 80 mg | ||||
eq. to Atorvastatin | ||||||
Excipients | q. s. | |||||
79 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayered Tablet Contains: | hypertension | |||
Telmisartan | IP | 80 mg | ||||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
80 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayered Tablet Contains: | hypertension | |||
Telmisartan | IP | 40 mg | ||||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 10 mg | ||||
Excipients | q. s. | |||||
81 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayered Tablet Contains: | hypertension | |||
Telmisartan | IP | 80 mg | ||||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 10 mg | ||||
Excipients | q. s. | |||||
82 | Glimepiride, Voglibose & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | sulfonylureas | |||
Glimepiride | ||||||
Voglibose | IP | 1 mg | ||||
Metformin Hydrochloride | IP | 0.2 mg | ||||
(As Sustained Release) | IP | 500 mg | ||||
Excipients | ||||||
q. s. | ||||||
83 | Glimepiride, Voglibose & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | Alpha glucosidase inhibitors | |||
Glimepiride | IP | 2 mg | ||||
Voglibose | IP | 0.2 mg | ||||
Metformin Hydrochloride | IP | 500 mg | ||||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
84 | Vidagliptin Tablets 50 mg | Each Uncoated Tablet Contains: | DPP-4 inhibitor. | |||
Vidagliptin | IP | 50 mg | ||||
Excipients | q. s. | |||||
85 | Teneligliptin & Metformin Hydrochloride (Extended Release) Tablets | Each Film coated bilayered Tablet Contains: | ||||
Teneligliptin hydrobromide hydrate | anti-diabetic | |||||
Eq. to Teneligliptin | IP | 20 mg | ||||
Metformin Hydrochloride | IP | 500 mg | ||||
(As Extended Release) | ||||||
Excipients | q. s. | |||||
86 | Teneligliptin & Metformin Hydrochloride (Extended Release) Tablets | Each Film coated bilayered Tablet Contains: | ||||
Teneligliptin hydrobromide hydrate | anti-diabetic | |||||
Eq. to Teneligliptin | IP | |||||
Metformin Hydrochloride | IP | 20 mg | ||||
(As Extended Release) | 1000 mg | |||||
Excipients | ||||||
q. s. | ||||||
87 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | sulfonylurea. | |||
Glimepiride | ||||||
Metformin Hydrochloride | IP | 1 mg | ||||
(As Sustained Release) | IP | 500 mg | ||||
Excipients | ||||||
q. s. | ||||||
88 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | sulfonylurea. | |||
Glimepiride | IP | 2 mg | ||||
Metformin Hydrochloride | IP | 500 mg | ||||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
89 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | sulfonylurea. | |||
Glimepiride | IP | 1 mg | ||||
Metformin Hydrochloride | IP | 1000 mg | ||||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
90 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | ||||
Glimepiride | IP | 2 mg | sulfonylurea. | |||
Metformin Hydrochloride | IP | 1000 mg | ||||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
91 | Voglibose & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | Alpha glucosidase inhibitor | |||
Voglibose | IP | 0.2 mg | ||||
Metformin Hydrochloride | IP | 500 mg | ||||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
92 | Voglibose & Metformin Hydrochloride (Sustained Release) Tablets | Each Film coated bilayered Tablet Contains: | ||||
Voglibose | IP | 0.3 mg | Alpha glucosidase inhibitor | |||
Metformin Hydrochloride | IP | 500 mg | ||||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
93 | Telmisartan & Metoprolol Succinate (Extended release) Tablets IP | Each Uncoated bilayered Tablet Contains: | ||||
Telmisartan | IP | 40 mg | hypertension | |||
Metoprolol Succinate | ||||||
Eq. to Metoprolol Tartrate | IP | 25 mg | ||||
(As Extended Release) | ||||||
Excipients | q. s. | |||||
94 | Clinidipine & Telmesartan, Chlorthalidone Tablets | Each Film Coated Tablet Contains: | ||||
Clinidipine | IP | 10 mg | hypertension | |||
Telmesartan | IP | 40 mg | ||||
Chlorthalidone | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
95 | Rivaroxaban Tablets 10 mg | Each Film Coated Tablet Contains: | Anticoagulant | |||
Rivaroxaban | IP | 10 mg | ||||
Excipients | q. s. | |||||
96 | Rivaroxaban Tablets 15 mg | Each Film Coated Tablet Contains: | Anticoagulant | |||
Rivaroxaban | IP | 15 mg | ||||
Excipients | q. s. | |||||
97 | Rivaroxaban Tablets 20 mg | Each Film Coated Tablet Contains: | ||||
Rivaroxaban | IP | 20 mg | Anticoagulant | |||
Excipients | q. s. | |||||
98 | Metoprolol Succinate (Prolonged Release) Tablets IP 25 mg | Each Film Coated Tablet Contains: | ||||
Metoprolol Succinate | IP | 25 mg | beta-blocker | |||
(As Prolonged Release) | ||||||
Excipients | q. s. | |||||
99 | Metoprolol Succinate (Prolonged Release) Tablets IP 50 mg | Each Film Coated Tablet Contains: | beta-blocker | |||
Metoprolol Succinate | IP | 50 mg | ||||
(As Prolonged Release) | ||||||
Excipients | q. s. | |||||
100 | Telmisartan & Chlorthalidone Tablets | Each Uncoated bilayered Tablet Contains: | Hypertension | |||
Telmisartan | IP | 40 mg | ||||
Chlorthalidone | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
121 | Telmisartan & Chlorthalidone Tablets | Each Uncoated bilayered Tablet Contains: | ||||
Telmisartan | IP | 40 mg | Hypertension | |||
Chlorthalidone | IP | 6.25 mg | ||||
Excipients | q. s. | |||||
122 | Metoprolol Succinate (Prolonged Release) Tablets IP 12.5 mg | Each Film Coated Tablet Contains: | ||||
Metoprolol Succinate | IP | 12.5 mg | beta blockers | |||
(As Prolonged Release) | ||||||
Excipients | q. s. | |||||
124 | Sitagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | dipeptidylpeptidase-4 inhibitors | |||
Sitagliptin Phosphate monohydrate | ||||||
Eq. to Sitagliptin | IP | 50 mg | ||||
Metformin Hydrochloride | IP | 500 mg | ||||
Excipients | q. s. | |||||
125 | Sitagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains: | ||||
Sitagliptin Phosphate monohydrate | dipeptidylpeptidase-4 inhibitors | |||||
Eq. to Sitagliptin | IP | 50 mg | ||||
Metformin Hydrochloride | IP | 1000 mg | ||||
Excipients | q. s. | |||||
126 | Torsemide Tablets IP 5 mg | Each Uncoated Tablet Contains: | ||||
Torsemide | IP | 5 mg | diuretics ('water pills'). | |||
Excipients | q. s. | |||||
127 | Torsemide Tablets IP 10 mg | Each Uncoated Tablet Contains: | ||||
Torsemide | IP | 10 mg | diuretics ('water pills'). | |||
Excipients | q. s. | |||||
128 | Torsemide Tablets IP 100 mg | Each Uncoated Tablet Contains: | ||||
Torsemide | IP | 100 mg | diuretics ('water pills'). | |||
Excipients | q. s. | |||||
129 | Telmisertan & Clinidipine Tablets | Each Film Coated Tablet Contains: | Hypertension | |||
Telmisertan | IP | 40 mg | ||||
Clinidipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
130 | Telmisertan & Clinidipine Tablets | Each Film Coated Tablet Contains: | ||||
Telmisertan | ||||||
Clinidipine | IP | 40 mg | ||||
Excipients | IP | 10 mg | ||||
q. s. | ||||||
131 | Telmisartan & Metoprolol Succinate (Extended release) Tablets IP | Each Uncoated bilayered Tablet Contains: | Hypertension | |||
Telmisartan | ||||||
Metoprolol Succinate | IP | 40 mg | ||||
Eq. to Metoprolol Tartrate | ||||||
(As Extended Release) | IP | 50 mg | ||||
Excipients | ||||||
q. s. | ||||||
132 | Sitagliptin Tablets | Each Film Coated Tablet Contains: | ||||
Sitagliptin Phosphate monohydrate | Anti-Diabetes | |||||
Eq. to Sitagliptin | IP | 25 mg | ||||
Excipients | q. s. | |||||
133 | Sitagliptin Tablets | Each Film Coated Tablet Contains: | Anti-Diabetes | |||
Sitagliptin Phosphate monohydrate | ||||||
Eq. to Sitagliptin | IP | 50 mg | ||||
Excipients | q. s. | |||||
134 | Sitagliptin Tablets | Each Film Coated Tablet Contains: | ||||
Sitagliptin Phosphate monohydrate | ||||||
Eq. to Sitagliptin | IP | 100 mg | Anti-Diabetes | |||
Excipients | q. s. | |||||
135 | Gliclazide & Metformin hydrochloride (Extanded Release) Tablets | Each Film Coated bilayered Tablet Contains: | ||||
Gliclazide | IP | 30 mg | sulfonylurea. | |||
(As Extended Release) | ||||||
Metformin hydrochloride | IP | 500 mg | ||||
(As Extended Release) | ||||||
Excipients | q. s. | |||||
136 | Gliclazide & Metformin hydrochloride (Extanded Release) Tablets | Each Film Coated bilayered Tablet Contains: | ||||
Gliclazide | IP | 60 mg | sulfonylurea. | |||
(As Extended Release) | ||||||
Metformin hydrochloride | IP | 500 mg | ||||
(As Extended Release) | ||||||
Excipients | q. s. | |||||
137 | Gliclazide Modified Release Tablets 30 mg | Each Uncoated Modified Release Tablet Contains: | ||||
Gliclazide | IP | 30 mg | sulfonylurea. | |||
(As Modified Release) | ||||||
Excipients | q. s. | |||||
138 | Gliclazide Modified Release Tablets 60 mg | Each Uncoated Modified Release Tablet Contains: | ||||
Gliclazide | IP | 60 mg | ||||
(As Modified Release) | sulfonylurea. | |||||
Excipients | q. s. | |||||
139 | Repaglinide Tablet IP 0.5 mg | Each Uncoated Tablet Contains: | ||||
Repaglinide | IP | 0.5 mg | Anti-diabetes | |||
Excipients | q. s. | |||||
140 | Repaglinide Tablet IP 1 mg | Each Uncoated Tablet Contains: | ||||
Repaglinide | IP | 1 mg | Anti-diabetes | |||
Excipients | q. s. | |||||
141 | Repaglinide Tablet IP 2 mg | Each Uncoated Tablet Contains: | ||||
Repaglinide | IP | 2 mg | Anti-diabetes | |||
Excipients | q. s. | |||||
142 | Repaglinide & Metformin hydrochloride Tablet IP | Each Film Coated Tablet Contains: | ||||
Repaglinide | IP | 1 mg | Anti-diabetes | |||
Metformin hydrochloride | IP | 500 mg | ||||
Excipients | q. s. | |||||
143 | Repaglinide & Metformin hydrochloride Tablet IP | Each Film Coated Tablet Contains: | ||||
Repaglinide | IP | 2 mg | ||||
Metformin hydrochloride | IP | 500 mg | Anti-diabetes | |||
Excipients | q. s. | |||||
144 | Atorvastatin Tablets IP 10 mg | Each Film Coated Tablet Contains: | ||||
Atorvastatin Calcium | IP | 10 mg | HMG-CoA reductase inhibitors | |||
eq. to Atorvastatin | ||||||
Excipients | q. s. | |||||
145 | Atorvastatin Tablets IP 40 mg | Each Film Coated Tablet Contains: | ||||
Atorvastatin Calcium | IP | 40 mg | HMG-CoA reductase inhibitors | |||
eq. to Atorvastatin | ||||||
Excipients | q. s. | |||||
146 | Metoprolol Succinate (Sustained Release) & Amlodipine Tablets IP | Each Film Coated bilayered Tablet Contains: | ||||
Metoprolol Succinate | beta-blocker | |||||
Eq. to Metoprolol Tartrate | IP | 50 mg | ||||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
147 | Metoprolol Succinate (Sustained Release) & Amlodipine Tablets IP | Each Film Coated bilayered Tablet Contains: | ||||
Metoprolol Succinate | ||||||
Eq. to Metoprolol Tartrate | IP | 25 mg | beta-blocker | |||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
148 | Dapagliflozin Tablets 5 mg | Each Film Coated Tablet Contains: | ||||
Dapagliflozin propanediol monohydrate | sodium-glucose co-transporte | |||||
Eq. to Dapagliflozin | 5 mg | |||||
Excipients | q. s. | |||||
149 | Dapagliflozin Tablets 5 mg | Each Film Coated Tablet Contains: | ||||
Dapagliflozin propanediol monohydrate | ||||||
Eq. to Dapagliflozin | 10 mg | sodium-glucose co-transporte | ||||
Excipients | q. s. | |||||
150 | Empagliflozin Tablets 10 mg | Each Film Coated Tablet Contains: | ||||
Empagliflozin | 10 mg | Antidiabetes | ||||
Excipients | q. s. | |||||
151 | Empagliflozin Tablets 20 mg | Each Film Coated Tablet Contains: | ||||
Empagliflozin | 20 mg | Antidiabetes | ||||
Excipients | q. s. | |||||
152 | Empagliflozin Tablets 25 mg | Each Film Coated Tablet Contains: | ||||
Empagliflozin | 25 mg | Antidiabetes | ||||
Excipients | q. s. | |||||
153 | Saxagliptin & Metformin hydrochloride (Extended Release) Tablets IP | Each Film Coated bilayered Tablet Contains: | ||||
Saxagliptin hydrochloride | ||||||
Eq. to Saxagliptin | 5 mg | sodium-glucose co-transporter | ||||
Metformin hydrochloride | IP | 1000 mg | ||||
(As Extended Release) | ||||||
Excipients | q. s. | |||||
154 | Metformin hydrochloride (Sustained Release) Tablets IP | Each Uncoated Sustained Release Tablet Contains: | ||||
Metformin hydrochloride | IP | 500 mg | biguanides. | |||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
155 | Metformin hydrochloride (Sustained Release) Tablets IP | Each Uncoated Sustained Release Tablet Contains: | ||||
Metformin hydrochloride | IP | 850 mg | biguanides. | |||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
156 | Metformin hydrochloride (Sustained Release) Tablets IP | Each Uncoated Sustained Release Tablet Contains: | ||||
Metformin hydrochloride | IP | 1000 mg | biguanides. | |||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
157 | Metformin hydrochloride Tablets IP | Each Uncoated Tablet Contains: | ||||
Metformin hydrochloride | IP | 500 mg | biguanides. | |||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
159 | Metformin hydrochloride Tablets IP | Each Uncoated Tablet Contains: | ||||
Metformin hydrochloride | IP | 850 mg | biguanides. | |||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
160 | Metformin hydrochloride Tablets IP | Each Uncoated Tablet Contains: | ||||
Metformin hydrochloride | IP | 1000 mg | biguanides. | |||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
161 | Ticagrelor Tablets IP 60 mg | Each Film Coated Tablet Contains: | ||||
Ticagrelor | IP | 60 mg | Antithrombotic | |||
Excipients | q. s. | |||||
162 | Ticagrelor Tablets IP 90 mg | Each Film Coated Tablet Contains: | ||||
Ticagrelor | IP | 90 mg | Antithrombotic | |||
Excipients | q. s. | |||||
163 | Rosuvastatin & Ezetimibe Tablets IP | Each Film Coated Tablet Contains: | ||||
Rosuvastatin Calcium | Cholesterol absorption inhibitor | |||||
Eq. to Rosuvastatin | IP | 10 mg | ||||
Ezetimibe | IP | 10 mg | ||||
Excipients | q. s. | |||||
164 | Rosuvastatin & Ezetimibe Tablets IP | Each Film Coated Tablet Contains: | ||||
Rosuvastatin Calcium | Cholesterol absorption inhibitor | |||||
Eq. to Rosuvastatin | IP | 20 mg | ||||
Ezetimibe | IP | 10 mg | ||||
Excipients | q. s. | |||||
165 | Ezetimibe Tablets IP | Each Uncoated Tablet Contains: | ||||
Ezetimibe | IP | 10 mg | absorption of cholesterol | |||
Excipients | q. s. | |||||
166 | Torsemide & Spironolactone Tablets IP | Each Uncoated Tablet Contains: | ||||
Torsemide | IP | 10 mg | Aldosterone Antagonists | |||
Spironolactone | IP | 50 mg | ||||
Excipients | q. s. | |||||
177 | Torsemide & Spironolactone Tablets IP | Each Uncoated Tablet Contains: | ||||
Torsemide | IP | 20 mg | Aldosterone Antagonists | |||
Spironolactone | IP | 50 mg | ||||
Excipients | q. s. | |||||
178 | Cilnidipine & Metoprolol Succinate (ER) Tablets | Each Uncoated bilayered Tablets Contains: | ||||
Cilnidipine | IP | 10 mg | Hypertension | |||
Metoprolol Succinate | ||||||
Eq. to Metoprolol Tartrate | IP | 50 mg | ||||
(In Extended Release form) | ||||||
Excipients | q. s. | |||||
179 | Cilnidipine & Metoprolol Succinate (ER) Tablets | Each Uncoated bilayered Tablets Contains: | ||||
Cilnidipine | IP | 10 mg | Hypertension | |||
Metoprolol Succinate | ||||||
Eq. to Metoprolol Tartrate | IP | 25 mg | ||||
(In Extended Release form) | ||||||
Excipients | q. s. | |||||
180 | Olmesartan Medoxomil Tablets IP 10 mg | Each Film Coated Tablet Contains: | ||||
Olmesartan Medoxomil | IP | 10 mg | hypertension | |||
Excipients | q. s. | |||||
181 | Olmesartan Medoxomil & Amlodipine Tablets | Each Film Coated Tablet Contains: | ||||
Olmesartan Medoxomil | IP | 40 mg | hypertension | |||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
182 | Olmesartan Medoxomil, Amlodipine & Hydrochlorothiazide Tablets | Each Film Coated Tablet Contains: | ||||
Olmesartan Medoxomil | IP | 40 mg | hypertension | |||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Hydrochlorothiazide | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
183 | Olmesartan Medoxomil, Amlodipine & Hydrochlorothiazide Tablets | Each Film Coated Tablet Contains: | ||||
Olmesartan Medoxomil | IP | 20 mg | hypertension | |||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Hydrochlorothiazide | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
184 | Clopidogrel Bisulphate Tablets | Each Film Coated Tablet Contains: | ||||
Clopidogrel Bisulphate | Antithrombotic. | |||||
Eq. to Clopidogrel | IP | 75 mg | ||||
Excipients | q. s. | |||||
185 | Pregabalin & Methylcobalamin Tablets | Each Film Coated Tablet Contains: | ||||
Pregabalin | IP | 75 mg | vitamin B12 | |||
Methylcobalamin | IP | 750 mcg | ||||
Excipients | q. s. | |||||
186 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains: | ||||
Levofloxacin hemi-hydrate | antibiotics | |||||
Eq. to Levofloxacin | IP | 750 mg | ||||
Excipients | q. s. | |||||
Colour: Red Oxide of Iron, Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
187 | Atorvastatin Tablets IP 20 mg | Each Film Coated Tablet Contains: | Statin | |||
Atorvastatin Calcium | ||||||
Eq. to Atorvastatin | IP | 20 mg | ||||
Excipients | q. s. | |||||
188 | Cholecalciferol chewable tablet 60,000IU | Each Uncoated chewable Tablet Contains: | ||||
Cholecalciferol | IP | 60,000 IU | vitamin | |||
Excipients | q. s. | |||||
Colour: Lake Sunset Yellow | ||||||
189 | Calcium Citrate, Vitamin D3, Magnesium Hydroxide & Zinc Sulphate Tablets | Each Film Coated Tablet Contains: | ||||
Calcium Citrate | USP | 1000 mg | ||||
Vitamin D3 | IP | 200 IU | vitamin | |||
Magnesium Hydroxide | ||||||
Eq. to Elemental Magnesium Zinc Sulphate | ||||||
Monohydrate IP | IP | 100 mg | ||||
Excipients | ||||||
190 | Ofloxacin & Satranidazole Tablets | Each Film Coated Tablet Contains: | ||||
Ofloxacin | IP | 200 mg | quinolone antibiotics | |||
Satranidazole | 300 mg | |||||
Excipients | q. s. | |||||
191 | Paracetamol, phenylephrine Hcl, Caffeine & Diphenhydramine Hcl Tablets | Each Uncoated Tablet Contains: | ||||
Paracetamol | IP | 325 mg | antiallergic | |||
Phenylephrine Hcl | IP | 5 mg | ||||
Caffeine (Anhydrous) | IP | 30 mg | ||||
Diphenhydramine Hcl | IP | 25 mg | ||||
Excipients | q. s. | |||||
192 | Frusemide Tablets IP | Each Uncoated Tablet Contains: | ||||
Frusemide | IP | 40 mg | Diuretic | |||
Excipients | q. s. | |||||
193 | Etoricoxib Tablets IP 90 mg | Each Film Coated Tablet Contains: | ||||
Etoricoxib | IP | 90 mg | anti-inflammatory drugs | |||
Excipients | q. s. | |||||
194 | Citicoline & Piracetam Tablets | Each Film Coated Tablet Contains: | psychostimulants and nootropics. | |||
Citicoline Sodium | ||||||
Eq. to Citicoline | IP | 500 mg | ||||
Piracetam | IP | 400 mg | ||||
Excipients | q. s. | |||||
195 | Artemether & Lumefantrine Tablets | Each Uncoated Tablet Contains: | Antimalarials | |||
Artemether | IP | 20 mg | ||||
Lumefantrine | 120 mg | |||||
Excipients | q. s. | |||||
196 | Artemether & Lumefantrine Dispersible Tablets | Each Uncoated Dispersible Tablet Contains: | ||||
Artemether | IP | 40 mg | Antimalarials | |||
Lumefantrine | 240 mg | |||||
Excipients | q. s. | |||||
197 | Artemether & Lumefantrine Tablets | Each Filmcoated Tablets Contains: | ||||
Artemether | IP | 80 mg | Antimalarials | |||
Lumefantrine | 480 mg | |||||
Excipients | q. s. | |||||
198 | Vitamin C Chewable Tablets | Each Uncoated Tablet Contains: | ||||
Ascorbic Acid | IP | 100 mg | Vitamin | |||
Sodium Ascorbate | IP | 450 mg | ||||
Eq. to Ascorbic Acid | 400 mg | |||||
Excipients | q. s. | |||||
Colour: Sunset Yellow FCF | ||||||
199 | Nimesulide, Phenylephrine hydrochloride & Levocetirizine Hydrochloride Tablets | Each Uncoated Tablet Contains: | ||||
Nimesulide | BP | 100 mg | anti-inflammatory drug | |||
Phenylephrine hydrochloride | IP | 5 mg | ||||
Levocetirizine Hydrochloride | IP | 5 mg | ||||
Excipients | q. s. | |||||
200 | Levocetirizine hydrochloride, Phenyleprine hydrochloride & Paracetamol Tablets | Each Uncoated Tablet Contains: | ||||
Levocetirizine hydrochloride | IP | 5 mg | antiallergic | |||
Phenyleprine hydrochloride | IP | 5 mg | ||||
Paracetamol | IP | 325 mg | ||||
Excipients | q. s. | |||||
201 | Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Each Film Coated Tablet Contains: | ||||
Aceclofenac | IP | 100 mg | ||||
Paracetamol | IP | 325 mg | anti-inflammatory drug | |||
Serratiopeptidase (As enteric coated granules) | IP | 15 mg | ||||
Eq. to 30,000 Serratiopeptidase Units) | ||||||
Excipients | q. s. | |||||
202 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each Film Coated Tablet Contains: | ||||
Aceclofenac | IP | 100 mg | inflammation (redness and swelling) | |||
Paracetamol | IP | 325 mg | ||||
Chlorzoxazone | USP | 500 mg | ||||
Excipients | q. s. | |||||
203 | Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Each Film Coated Tablet Contains: | ||||
Aceclofenac | IP | 100 mg | anti-inflammatory drug | |||
Paracetamol | IP | 325 mg | ||||
Serratiopeptidase (As enteric coated granules) | IP | 10 mg | ||||
Eq. to 20,000 Serratiopeptidase Units) | ||||||
Excipients | q. s. | |||||
204 | Acebrophylline, Fexofenadine hydrochloride & Montelukast Tablets | Each Film Coated Tablet Contains: | ||||
Acebrophylline | 200 mg | acute or chronic bronchitis | ||||
(As Sustained Release) | ||||||
Fexofenadine hydrochloride | IP | 120 mg | ||||
Montelukast Sodium | ||||||
Eq. to Montelukast | IP | 10 mg | ||||
Excipients | ||||||
205 | Phenylephrine Hcl, Dextromethorpan Hcl, Cetirizine, Ambroxol Hcl & Guaiphenesin Tablets | Each 5 ml contains: | ||||
Phenylephrine hydrochloride | IP | 15 mg | ||||
Cetirizine hydrochloride | IP | 5 mg | Anti-allgeric | |||
Ambroxol hydrochloride | IP | 30 mg | ||||
Dextromethorpan hydrochloride | IP | 10 mg | ||||
Guaiphenesin | IP | 100 mg | ||||
Excipients | q. s. | |||||
206 | Nimesulide, Paracetamol, Phenylephrine hydrochloride & Caffeine Tablets | Each Uncoated Tablet Contains: | ||||
Nimesulide | 100 mg | anti-inflammatory drug | ||||
Paracetamol | 325 mg | |||||
Phenylephrine hydrochloride | 10 mg | |||||
Caffeine (Anhydrous) | 25 mg | |||||
Excipients | q. s. | |||||
207 | Diclofenac Sodium, Paracetamol, Cetirizine & Magnesium Trisilicate Tablets | Each Uncoated Tablet Contains: | anti-inflammatory drug | |||
Each Uncoated Tablet Contains: | IP | 50 mg | ||||
Paracetamol | IP | 325 mg | ||||
Cetirizine Dihydrochloride | IP | 5 mg | ||||
Magnesium Trisilicate | IP | 100 mg | ||||
Excipients | q. s. | |||||
208 | Ascorbic acid tablets 100 mg | Each uncoated chewable tablets contains: | ||||
Ascorbic acid | IP | 100 mg | Vitamin | |||
Excipients | q. s. | |||||
Approved colour used in tablets | ||||||
209 | Carbonyl Iron, Folic Acid, Vitamin B12 & Zinc Sulphate Tablets | Each Film Coated Tablet Contains: | ||||
Carbonyl iron | IP | 100mg | Vitamin | |||
Eq.to elemental iron | ||||||
Folic acid | IP | 1.5mg | ||||
Vitamin B12 | IP | 15mg | ||||
Zinc sulphate monohydrate | IP | 22.5mg | ||||
Excipients | q. s. | |||||
Approbved colour used in tablets | ||||||
210 | Thiamine hydrochloride Tablets 100 mg | Each Film Coated Tablet Contains: | vitamin | |||
Thiamine hydrochloride | IP | 100mg | ||||
Excipients | q. s. | |||||
Approbved colour used in tablets | ||||||
211 | Ferrous Ascorbate, Folic Acid, Cyanocobalamin & Zinc Sulphate Tablets | Each Film Coated Tablet Contains: | vitamin | |||
Ferrous ascorbate | ||||||
Eq.to elemental iron | IP | 100mg | ||||
Folic acid | IP | 1.5mg | ||||
Cyanocobalamin triturate | ||||||
Eq.to Cyanocobalamin | IP | 7.5mg | ||||
Zinc sulphate monohydrate | IP | 22.5mg | ||||
Eq.to elemental zinc | q. s. | |||||
Excipients | ||||||
Approbved colour used in tablets | ||||||
212 | Aceclofenac & Serratiopeptidase Tablets | Each Film Coated Tablet Contains: | ||||
Aceclofenac | IP | 100 mg | anti-inflammatory drug | |||
Serratiopeptidase | IP | 15 mg | ||||
(As enteric Coated granules) | ||||||
Eq. to 30,000 Serratiopeptidase Unit | ||||||
Excipients | q. s. | |||||
213 | Aceclofenac & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: | ||||
Aceclofenac | IP | 100 mg | anti-inflammatory drug | |||
Thiocolchicoside | IP | 4 mg | ||||
Excipients | q. s. | |||||
214 | Aceclofenac & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: | ||||
Aceclofenac | IP | 100 mg | anti-inflammatory drug | |||
Thiocolchicoside | IP | 8 mg | ||||
Excipients | q. s. | |||||
215 | Aceclofenac Sustained Release Tablets | Each Film Coated Sustained release Tablets Contains: | ||||
Aceclofenac | IP | 200 mg | anti-inflammatory drug | |||
Excipients | q. s. | |||||
216 | Aceclofenac, Paracetamol & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: | anti-inflammatory drug | |||
Aceclofenac | IP | 100 mg | ||||
Paracetamol | IP | 325 mg | ||||
Thiocolchicoside | IP | 4 mg | ||||
Excipients | q. s. | |||||
217 | Aceclofenac, Paracetamol & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: | anti-inflammatory drug | |||
Aceclofenac | IP | 100 mg | ||||
Paracetamol | IP | 325 mg | ||||
Thiocolchicoside | IP | 8 mg | ||||
Excipients | q. s. | |||||
218 | Aceclofenac, Paracetamol & Chorzoxazone Tablets | Each Film Coated Tablet Contains: | anti-inflammatory drug | |||
Aceclofenac | IP | 100 mg | ||||
Paracetamol | IP | 325 mg | ||||
Chorzoxazone | USP | 500 mg | ||||
Excipients | q. s. | |||||
219 | Aceclofenac, Paracetamol & Chorzoxazone Tablets | Each Film Coated Tablet Contains: | anti-inflammatory drug | |||
Aceclofenac | IP | 100 mg | ||||
Paracetamol | IP | 325 mg | ||||
Chorzoxazone | USP | 250 mg | ||||
Excipients | q. s. | |||||
220 | Aceclofenac, Paracetamol & Chorzoxazone Tablets | Each Uncoated Tablet Contains: | anti-inflammatory drug | |||
Aceclofenac | IP | 100 mg | ||||
Paracetamol | IP | 325 mg | ||||
Chorzoxazone | USP | 250 mg | ||||
Excipients | q. s. | |||||
221 | Acyclovir Tablets IP 800 mg | Each Uncoated Tablet Contains: | Anti-viral | |||
Acyclovir | IP | 800 mg | ||||
Excipients | q. s. | |||||
222 | Acyclovir Dispersible Tablets IP 200 mg | Each Uncoated Dispersible Tablet Contains: | Anti-viral | |||
Acyclovir | IP | 200 mg | ||||
Excipients | q. s. | |||||
223 | Acyclovir Dispersible Tablets IP 400 mg | Each Uncoated Dispersible Tablet Contains: | ||||
Acyclovir | IP | 400 mg | Anti-viral | |||
Excipients | q. s. | |||||
224 | Ivermectin & Albendazole Tablets | Each Uncoated Tablet Contains: | antihelmintics | |||
Ivermectin | BP | 6 mg | ||||
Albendazole | IP | 400 mg | ||||
Excipients | q. s. | |||||
225 | Amlodipine and Atenolol Tablets | Each Uncoated Tablet Contains: | ||||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Atenolol | IP | 25 mg | ||||
Excipients | q. s. | |||||
226 | Amlodipine and Atenolol Tablets | Each Uncoated Tablet Contains: | calcium channel blockers | |||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Atenolol | IP | 50 mg | ||||
Excipients | q. s. | |||||
227 | Amlodipine and Telmisartan Tablets | Each Uncoated Tablet Contains: | hypersion | |||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Telmisartan | IP | 80 mg | ||||
Excipients | q. s. | |||||
228 | Artemether & Lumefantrine Dispersible Tablets | Each Uncoated Dispersible Tablet Contains: | Anti-malarial. | |||
Artemether | IP | 20 mg | ||||
Lumefantrine | 120 mg | |||||
Excipients | q. s. | |||||
229 | Artemether & Lumefantrine Tablets | Each Uncoated Tablet Contains: | Anti-malarial. | |||
Artemether | IP | 80 mg | ||||
Lumefantrine | 480 mg | |||||
Excipients | q. s. | |||||
230 | Artemether & Lumefantrine Tablets | Each Uncoated Tablet Contains: | ||||
Artemether | IP | 20 mg | ||||
Lumefantrine | 120 mg | |||||
Excipients | q. s. | |||||
231 | Artemether & Lumefantrine Tablets | Each Film Coated Tablet Contains: | Anti-malarial. | |||
Artemether | IP | 80 mg | ||||
Lumefantrine | 480 mg | |||||
Excipients | q. s. | |||||
232 | Artesunate, Sulphadoxine & Pyrimethamine Combi Kit | Each Combi Kit Contains: | ||||
(A) 1 Sulphadoxine and Pyrimethamine Tablets IP | ||||||
Each Uncoated Tablet Contains: | Antimalarial. | |||||
Sulphadoxine | IP | 500 mg | ||||
Pyrimethamine | IP | 25 mg | ||||
(B) 2 Artesunate Tablets | ||||||
Each Uncoated Tablet Contains: | ||||||
Artesunate | IP | 100 mg | ||||
Approbved colour used in tablets | ||||||
233 | Artesunate, Sulphadoxine & Pyrimethamine Combi Kit | Each Combi Kit Contains: | ||||
(A) 1 Sulphadoxine and Pyrimethamine Tablets IP | ||||||
Each Uncoated Tablet Contains: | Antimalarial. | |||||
Sulphadoxine | IP | 500 mg | ||||
Pyrimethamine | IP | 25 mg | ||||
(B) 2 Artesunate Tablets | ||||||
Each Uncoated Tablet Contains: | ||||||
Artesunate | IP | 50 mg | ||||
Approbved colour used in tablets | ||||||
234 | Artesunate, Sulphadoxine & Pyrimethamine Combi Kit | Each Combi Kit Contains: | ||||
(A) 1 Sulphadoxine and Pyrimethamine Tablets IP | ||||||
Each Uncoated Tablet Contains: | Antimalarial. | |||||
Sulphadoxine | IP | 750 mg | ||||
Pyrimethamine | IP | 37.5 mg | ||||
(B) 2 Artesunate Tablets | ||||||
Each Uncoated Tablet Contains: | ||||||
Artesunate | IP | 200 mg | ||||
Approbved colour used in tablets | ||||||
235 | Clonazapam Mouth Dissolving Tablets 0.25 mg | Each Uncoated Mouth Dissolving Tablet Contains: | anticonvulsant or antiepileptic drug | |||
Clonazapam | IP | 0.25 mg | ||||
Excipients | q. s. | |||||
236 | Clonazapam Mouth Dissolving Tablets 0.5 mg | Each Uncoated Mouth Dissolving Tablet Contains: | ||||
Clonazapam | IP | 0.5 mg | anticonvulsant or antiepileptic drug | |||
Excipients | q. s. | |||||
237 | Clopidogrel & Aspirin Tablets | Each Film Coated Tablet Contains: | Thienopyridine | |||
Clopidogrel Bisulphate | ||||||
Eq. to Clopidogrel | IP | 75 mg | ||||
Aspirin | IP | 150 mg | ||||
Excipients | q. s. | |||||
238 | Diclofenac Sodium Tablets IP 50 mg | Each Uncoated Tablet Contains: | inflammatory drugs (NSAIDs | |||
Diclofenac Sodium | ||||||
(As enteric Coated granules) | IP | 50 mg | ||||
Excipients | q. s. | |||||
239 | Disulfiram Tablets IP 500 mg | Each Uncoated Tablet Contains: | Psychiatry Agents | |||
Disulfiram | IP | 500 mg | ||||
Excipients | q. s. | |||||
240 | Drotaverine Tablets IP 40 mg | Each Film Coated Tablet Contains: | anti-spasmodic | |||
Drotaverine hydrochloride | IP | 40 mg | ||||
Excipients | q. s. | |||||
241 | Drotaverine Tablets IP 80 mg | Each Film Coated Tablet Contains: | anti-spasmodic | |||
Drotaverine hydrochloride | IP | 40 mg | ||||
Excipients | q. s. | |||||
242 | Escitalopram Tablet IP 5 mg | Each Film Coated Tablet Contains: | selective serotonin reuptake inhibitors | |||
Escitalopram Oxalate | depression and anxiety. | |||||
Eq. to Escitalopram | IP | 5 mg | ||||
Excipients | q. s. | |||||
243 | Escitalopram Tablet IP 20 mg | Each Film Coated Tablet Contains: | ||||
Escitalopram Oxalate | selective serotonin reuptake inhibitors | |||||
Eq. to Escitalopram | IP | 20 mg | depression and anxiety. | |||
Excipients | q. s. | |||||
244 | Glibenclamide & Metformin Tablets | Each Uncoated Tablet Contains: | antidiabetic medicines: | |||
Glibenclamide | IP | 2.5 mg | ||||
Metformin Hcl | IP | 400 mg | ||||
Excipients | q. s. | |||||
245 | Glibenclamide & Metformin Tablets | Each Uncoated Tablet Contains: | ||||
Glibenclamide | IP | 5 mg | antidiabetic medicines: | |||
Metformin Hcl | IP | 500 mg | ||||
Excipients | q. s. | |||||
246 | Glimepiride & Metformin Prolonged Release Tablets IP | Each Uncoated bilayered Tablets Contains: | ||||
Glimepiride | IP | 1 mg | Hypoglycaemic. | |||
Metformin Hcl (As Extended Release) | IP | 500 mg | ||||
Excipients | q. s. | |||||
247 | Glimepiride & Metformin Prolonged Release Tablets IP | Each Uncoated bilayered Tablets Contains: | ||||
Glimepiride | IP | 2 mg | Hypoglycaemic. | |||
Metformin Hcl (As Extended Release) | IP | 500 mg | ||||
Excipients | q. s. | |||||
249 | Hydroxychloroquien Sulphate Tablets IP 200 mg | Each Film Coated Tablet Contains: | antimalarials | |||
Hydroxychloroquien Sulphate | IP | 200 mg | ||||
Excipients | q. s. | |||||
250 | Hydroxychloroquien Sulphate Tablets IP 400 mg | Each Film Coated Tablet Contains: | antimalarials | |||
Hydroxychloroquien Sulphate | IP | 400 mg | ||||
Excipients | q. s. | |||||
251 | Ivermectin & Albendazole Tablets | Each Uncoated Tablet Contains: | antihelmintics. | |||
Ivermectin | BP | 12 mg | ||||
Albendazole | IP | 400 mg | ||||
Excipients | q. s. | |||||
252 | Levocetirizine & Ambroxol hydrochloride Sustained Release Tablets | Each Uncoated bilayered Tablets Contains: | antiallergic | |||
Levocetirizine Dihydrochloride | IP | 5 mg | ||||
Ambroxol hydrochloride (In Sustained release form) | IP | 75 mg | ||||
Excipients | q. s. | |||||
253 | Losartan Potassium & Amlodipine Tablets IP | Each Film Coated Tablet Contains: | angiotensin receptor blockers | |||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Losartan Potassium | IP | 50 mg | ||||
Excipients | q. s. | |||||
254 | Losartan Potassium & hydrochlorothiazide Tablets IP | Each Film Coated Tablet Contains: | ||||
Losartan Potassium | IP | 50 mg | angiotensin receptor blockers | |||
Hydrochlorothiazide | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
255 | Ondansetron Tablets IP 4 mg | Each Film Coated Tablet Contains: | ||||
Ondansetron Hcl | 5-HT3 receptor antagonists | |||||
Eq. to Ondansertron | IP | 4 mg | ||||
Excipients | q. s. | |||||
256 | Ondansetron Tablets IP 8 mg | Each Film Coated Tablet Contains: | 5-HT3 receptor antagonists | |||
Ondansetron Hcl | ||||||
Eq. to Ondansertron | IP | 8 mg | ||||
Excipients | q. s. | |||||
257 | Pantaprazole & Domperidone Tablets | Each enteric Coated Tablet contains: | ||||
Pantaprazole Sodium Sesquihydrate | proton pump inhibitors | |||||
Eq. to Pantaprazole | IP | 40 mg | ||||
Domperidone | IP | 10 mg | ||||
Excipients | q. s. | |||||
258 | Pantaprazole & Domperidone Tablets | Each enteric Coated Tablet contains: | proton pump inhibitors | |||
Pantaprazole Sodium Sesquihydrate | ||||||
Eq. to Pantaprazole | IP | 20 mg | ||||
Domperidone | IP | 10 mg | ||||
Excipients | q. s. | |||||
259 | Pantaprazole Tablets IP 20 mg | Each enteric Coated Tablet contains: | proton pump inhibitors | |||
Pantaprazole Sodium Sesquihydrate | ||||||
Eq. to Pantaprazole | IP | 20 mg | ||||
Excipients | q. s. | |||||
260 | Prochlorperazine Maleate Tablets IP 5 mg | Each Uncoated Tablet Contains: | phenothiazines. | |||
Prochlorperazine Maleate | IP | 5 mg | ||||
Excipients | q. s. | |||||
261 | Quinine Sulphate Tablets IP 100 mg | Each Film Coated Tablet Contains: | ||||
Quinine Sulphate | IP | 100 mg | antimalarials. | |||
Excipients | q. s. | |||||
262 | Quinine Sulphate Tablets IP 300 mg | Each Film Coated Tablet Contains: | antimalarials. | |||
Quinine Sulphate | IP | 300 mg | ||||
Excipients | q. s. | |||||
263 | Rabeprazole Tablets IP 20 mg | Each enteric Coated Tablet contains: | Proton-pump inhibitor | |||
Rabeprazole Sodium | IP | 20 mg | ||||
Excipients | q. s. | |||||
264 | Ranitidine & Domperidone Tablets | Each Film Coated Tablet Contains: | ||||
Ranitidine Hydrochloride | Proton-pump inhibitor | |||||
Eq. to Ranitidine | IP | 150 mg | ||||
Domperidone | IP | 10 mg | ||||
Excipients | q. s. | |||||
265 | Talmisartan & AmlodipineTablets IP | Each Uncoated Tablet Contains: | hypertension | |||
Telmisartan | IP | 40 mg | ||||
Amlodipine Besylate | ||||||
Eq. to Amlodipine | IP | 5 mg | ||||
Excipients | q. s. | |||||
267 | Talmisartan & AmlodipineTablets IP | Each Uncoated bilayered Tablet Contains: | hypertension | |||
Telmisartan | IP | 40 mg | ||||
Hydrochlothiazide | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
268 | Telmisartan &Hydrochlorthiazide Tablets IP | Each Uncoated bilayered Tablet Contains: | ||||
Telmisartan | IP | 80 mg | hypertension | |||
Hydrochlothiazide | IP | 12.5 mg | ||||
Excipients | q. s. | |||||
269 | Mefenamic Acid & Drotaverine hydrochloride Tablets | Each Film Coated Tablet Contains: | non-steroidal anti-inflammatory drug (NSAID) | |||
Mefenamic Acid | IP | 250 mg | ||||
Drotaverine hydrochloride | IP | 80 mg | ||||
Excipients | q. s. | |||||
270 | Etoricoxib Tablets IP 60 mg | Each Film Coated Tablet Contains: | ||||
Etoricoxib | IP | 60 mg | non-steroidal anti-inflammatory drugs (NSAIDs) | |||
Excipients | q. s. | |||||
271 | Etoricoxib Tablets IP 120 mg | Each Film Coated Tablet Contains: | ||||
Etoricoxib | IP | 120 mg | non-steroidal anti-inflammatory drugs (NSAIDs) | |||
Excipients | q. s. | |||||
272 | Voglibose, Glimepiride & Metformin hydrochloride (Sustained Release) Tablets | Each Uncoated bilayered Tablet Contains: | ||||
Voglibose | IP | 0.2 mg | biguanides | |||
Glimepiride | IP | 2 mg | ||||
Metformin hydrochloride | IP | 500 mg | ||||
(As Sustained Release) | ||||||
Excipients | q. s. | |||||
273 | Norfloxacin & Tinidazole Tablets | Each film coated Tablet Contains: | ||||
Norfloxacin | IP | 400 mg | anti-bacterial | |||
Tinidazole | IP | 600 mg | ||||
Excipients | q. s. | |||||
274 | Pantoprazole Gastro-resistant Tablets IP 20 mg | Each Gastro-resistant Tablets Contains: | pront-pump inhibitor | |||
Pantaprazole Sodium Sesquihydrate | ||||||
Eq. to Pantoprazole | IP | |||||
Excipients | ||||||
20 mg | ||||||
q. s. | ||||||
275 | Diclofenac Potassium, Paracetamol & Serratiopeptidase Tablets | Each film coated Tablet Contains: | (non-steroidal anti-inflammatory drugs) | |||
Diclofenac Potassium | BP | 50 mg | ||||
Paracetamol | IP | 325 mg | ||||
Serratiopeptidase | IP | 15 mg | ||||
(As 30,000 enzymatic units of Serratiopeptidase) | ||||||
Excipients | q. s. | |||||
Colour: Sunset Yellow Lake | ||||||
276 | Tranexamic Acid Tablets | Each film coated Tablet Contains: | antifibrinolytics | |||
Tranexamic Acid | IP | 500 mg | ||||
Excipients | q. s. | |||||
277 | Paracetamol, Levocetirizine hydrochloride, Dextromethorphan hydrochloride, phenylephrine hydrochloride & Caffeiene Tablets | Each Uncoated Tablet Contains: | ||||
Paracetamol | IP | 325 mg | antiallergic | |||
Levocetirizine hydrochloride | IP | 5 mg | ||||
Dextromethorphan hydrochloride | IP | 5 mg | ||||
Phenylephrine hydrochloride | IP | 5 mg | ||||
Caffeiene Anhydrous | IP | 30 mg | ||||
Excipients | q. s. | |||||
278 | Nimesulide, Paracetamol & Serratiopeptidase Tablets | Each Film coated Tablet Contains: | anti-inflammatory drug (NSAID) and Paracetamol is an antipyretic (fever reducer) | |||
Nimesulide | ||||||
Paracetamol | BP | 100 mg | ||||
Serratiopeptidase (Enteric Coated) | IP | 325 mg | ||||
(As 30,000 enzymatic units of Serratiopeptidase) | IP | 15 mg | ||||
Excipients | ||||||
q. s. | ||||||
279 | Nimesulide,phenylephrine hydrochloride, Cetirizine hydrochloride & Caffeiene Tablets | Each Uncoated Tablet Contains: | ||||
Nimesulide | IP | 100 mg | analgesic & anti-allegric | |||
Cetirizine hydrochloride | IP | 5 mg | ||||
Phenylephrine hydrochloride | IP | 10 mg | ||||
Caffeine Anhydrous | IP | 30 mg | ||||
Excipients | q. s. | |||||
280 | Aceclofenac, Paracetamol, Cetirizine, Phenylephrine Hcl & Caffeiene Tablets | Each Uncoated Tablet Contains: | ||||
Aceclofenac | IP | 100 mg | ||||
Paracetamol | IP | 325 mg | ||||
Cetirizine hydrochloride | IP | 10 mg | anti-pyretic and anti-allegric | |||
Phenylephrine hydrochloride | IP | 5 mg | ||||
Caffeine Anhydrous | IP | 25 mg | ||||
Excipients | q. s. | |||||
281 | Paracetamol, Levocetirizine hydrochloride, Phenylephrine hydrochloride, Caffeine Tablets | Each Film coated Tablet Contains: | ||||
Paracetamol | anti-pyretic and anti-allegric | |||||
Levocetirizine hydrochloride | IP | 325 mg | ||||
Phenylephrine hydrochloride | IP | 5 mg | ||||
Caffeine Anhydrous | IP | 10 mg | ||||
Excipients | IP | 30 mg | ||||
q. s. | ||||||
282 | Paracetamol, Phenylephrine hydrochloride, Chlorpheniramine Maleate & Caffeine Tablets | Each Film coated Tablet Contains: | ||||
Paracetamol | anti-pyretic and anti-allegric | |||||
Chlorpheniramine Maleate | IP | 325 mg | ||||
Phenylephrine hydrochloride | IP | 2 mg | ||||
Caffeine Anhydrous | IP | 10 mg | ||||
Excipients | IP | 30 mg | ||||
q. s. | ||||||
283 | Levocetirizine & Ambroxol hydrochloride Sustained Release Tablets | Each Film coated Tablet Contains: | ||||
Levocetirizine Dihydrochloride | anti-allegric | |||||
Ambroxol hydrochloride (In Sustained release form) | IP | 5 mg | ||||
Excipients | IP | 75 mg | ||||
q. s. | ||||||
284 | Diclofenac Sodium, Paracetamol Tablets | Each Uncoated Tablet Contains: | anti-inflammatory drug | |||
Diclofenac Sodium | IP | 50 mg | ||||
Paracetamol | IP | 325 mg | ||||
Excipients | q. s. | |||||
285 | Bromhexine Hcl, Guaiphenesin, Chlorpheniramine Maleate, Phenylphrine Hcl& Paracetamol Tablets | Each Film coated Tablet Contains: | ||||
Bromhexine hydrochloride | expectorants | |||||
Guaiphenesin | IP | 4 mg | ||||
Chlorpheniramine Maleate | IP | 50 mg | ||||
Phenylphrine hydrochloride | IP | 4 mg | ||||
Paracetamol | IP | 5 mg | ||||
Excipients | IP | 325 mg | ||||
q. s. | ||||||
286 | Etoricoxib & Thiocolchicoside Tablets | Each film coated Tablet Contains: | non-steroidal anti-inflammatory drugs (NSAIDs) | |||
Etoricoxib | IP | 60 mg | ||||
Thiocolchicoside | IP | 4 mg | ||||
Excipients | q. s. | |||||
287 | Ketoconazole Tablets IP 200 mg | Each Uncoated Tablet Contains: | antifungals. | |||
Ketoconazole | IP | 200 mg | ||||
Excipients | q. s. | |||||
288 | Glimepiride & Metformin Sustained Release Tablets IP | Each Film coated Tablet Contains: | ||||
Glimepiride | sulfonylureas | |||||
Metformin hydrochloride | IP | 1 mg | ||||
(Sustained Release) | IP | 1000 mg | ||||
Excipients | q. s. | |||||
289 | Calcium with Vitamin D3 Tablets | Each Uncoated Tablets Contains: | ||||
Calcium Carbonate (from an organic source oyster shell) | vitamin | |||||
Eq. to elemental calcium | 1.25 gm | |||||
Vtamin D3 | 500 mg | |||||
Excipients | 250 IU | |||||
q. s. | ||||||
290 | Diclofenac Potassium, Paracetamol & Chlorzoxazone Tablets | Each Film coated Tablet Contains: | ||||
Diclofenac Potassium | anti-inflammatory drugs | |||||
Paracetamol | BP | 50 mg | ||||
Chlorzoxazone | IP | 325 mg | ||||
Excipients | IP | 250 mg | ||||
q. s. | ||||||
291 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each Film coated Tablet Contains: | ||||
Aceclofenac | anti-inflammatory | |||||
Paracetamol | IP | 100 mg | ||||
Chlorzoxazone | IP | 325 mg | ||||
Excipients | IP | 250 mg | ||||
q. s. | ||||||
292 | Norfloxacin, Metronidazole & Simethicone Suspension | Each 5 ml contains: | ||||
Norfloxacin | IP | 100 mg | quinolone antibiotics. | |||
Metronidazole Benzoate | ||||||
Eq. to Metronidazole | IP | 120 mg | ||||
Simethicone | IP | 10 mg | ||||
In a Flavoured Syrup base | q. s. | |||||
Colour: Tartrazine | ||||||
293 | Azithromycin tablets | Each Film coated Tablet Contains: | macrolide antibiotics. | |||
Azithromycin | USP | |||||
(As Azithromycin Dihydrate) | ||||||
Excipients | 250 mg | |||||
Colour: Titanium Dioxide | ||||||
q.s. | ||||||
294 | Azithromycin tablets | Each Film coated Tablet Contains: | ||||
Azithromycin | macrolide antibiotics. | |||||
(As Azithromycin Dihydrate) | USP | 500 mg | ||||
Excipients | ||||||
Colour: Titanium Dioxide | q. s. | |||||
295 | Levofloxacin Tablets USP 250 mg | Each Film Coated Tablet Contains: | quinolone antibiotics | |||
Levofloxacin hemi-hydrate | ||||||
Eq. to Levofloxacin | USP | 250 mg | ||||
Excipients | q. s. | |||||
296 | Levofloxacin Tablets USP 500 mg | Each Film Coated Tablet Contains: | ||||
Levofloxacin hemi-hydrate | quinolone antibiotics | |||||
Eq. to Levofloxacin | USP | 500 mg | ||||
Excipients | q. s. | |||||
297 | Ciprofloxacin Tablets USP 250 mg | Each Film Coated Tablet Contains: | ||||
Ciprofloxacin hydrochloride | ||||||
Eq. to Ciprofloxacin | USP | 250 mg | Anti-bacterial | |||
Excipients | q. s. | |||||
298 | Ciprofloxacin Tablets USP 500 mg | Each Film Coated Tablet Contains: | ||||
Ciprofloxacin hydrochloride | Anti-bacterial | |||||
Eq. to Ciprofloxacin | USP | 500 mg | ||||
Excipients | q. s. | |||||
299 | Diclofenac Potassium Tablets USP 50 mg | Each Tablet Contains: | ||||
Diclofenac Potassium | USP | 50 mg | anti-inflammatory drug | |||
Excipients | ||||||
Colour: Sunset Yellow FCF | q. s. | |||||
300 | Rosuvastatin Tablets USP 10 mg | Each Film coated Tablet Contains: | Statin | |||
Rosuvastatin Calcium | ||||||
Eq. to Rosuvastatin | USP | |||||
10 mg | ||||||
301 | Rosuvastatin Tablets USP 20 mg | Each Film coated Tablet Contains: | Statin | |||
Rosuvastatin Calcium | ||||||
Eq. to Rosuvastatin | USP | 20 mg | ||||
302 | Atorvastatin Calcium Tablets USP 20mg | Each Film coated Tablet Contains: | statins | |||
Atorvastatin Calcium | ||||||
Excipients | USP | 20 mg | ||||
q. s. | ||||||
303 | Pregabalin Capsules 75 mg | Each Hard Gelatin Capsules Contains: | anticonvulsants | |||
Pregabalin | USP | 75 mg | ||||
304 | Meloxicam Tablets | Each Tablet Contains: | anti-inflammatory drugs | |||
Meloxicam | USP | 15 mg | ||||
305 | Metronidazole Tablets BP 500 mg | Each Hard Gelatin Capsules Contains: | antibiotic | |||
Metronizole | ||||||
Excipients | BP | 500 mg | ||||
q. s. | ||||||
306 | Levocetirizine Hydrochloride & Montelukast Sodium Tablets | Each Film coated Tablet Contains: | ||||
Levocetirizine Hydrochloride | USP | antihistamines | ||||
Montelukast Sodium | USP | 5 mg | ||||
Eq. to Montelukast | ||||||
Excipients | 10 mg | |||||
q. s. | ||||||
307 | Sildenafil Tablets | Each Hard Gelatin Capsules Contains: | ||||
Sildenafil Ctrate | (PDE) inhibitors. | |||||
Eq. to Sildenafil | USP | |||||
100 mg | ||||||
308 | Itopride Hydrochloride Tablets 50 mg | Each Film coated Tablet Contains: | propulsives | |||
Itopride Hydrochloride | ||||||
Excipients | 50 mg | |||||
q. s. | ||||||
309 | Calcium & Cholecalciferol Tablets BP | Each Uncoated Tablets Contains: | ||||
Calcium Carbonate | BP | 1.25 gm | vitamin D analogs. | |||
Eq. to elemental calcium | 500 mg | |||||
Cholecalciferol (Stabilised) | ||||||
Eq. to Cholecalciferol | BP | 250 IU | ||||
310 | Aceclofenac & Paracetamol Tablets | Each Film Coated Tablet Contains: | ||||
Aceclofenac | BP | 100 mg | antiinflammatory | |||
Paracetamol | BP | 325 mg | ||||
Excipients | q. s. | |||||
Colour: Titanium Dioxide USP | ||||||
311 | Ascorbic Acid (vitamin C) & Zinc Chewable Tablets | Each Chewable Contains: | ||||
Ascorbic acid | IP | 200 mg | Vitamin | |||
Sodium Ascorbate IP 338 mg | ||||||
Eq. to Ascorbic Acid | IP | 300 mg | ||||
Zinc Citrate NF | ||||||
Eq. to elemental Zinc | 5 mg | |||||
Excipients | q. s. | |||||
Colour: Sunset Yellow Lake | ||||||
312 | Chlorhexidine Gluconate Solution & Cetrimide Antiseptic Liquid | Composition: | ||||
Chlorhexidine Gluconate Solution | IP | 0.3%w/v | Anti-septic | |||
Cetrimide | 0.6% w/v | |||||
313 | Chlorhexidine Gluconate, Cetrimide & Iso propyl Alcohol Concentration Solution | Composition: | ||||
Chlorhexidine Gluconate Solution | IP | 7.5 %V/v | Anti-septic | |||
Cetrimide | IP | 15 % w/v | ||||
Iso propyl Alcohol | 7.5% v/v | |||||
314 | Spironolactone Tablets IP | Each Uncoated Tablets Contains: | ||||
Spironolactone | IP | 100 mg | aldosterone receptor antagonists | |||
Excipients | q. s. | |||||
315 | Cilostazol Tablets IP | Each Uncoated Tablets Contains: | ||||
Cilostazol | IP | 50 mg | antiplatelet | |||
Excipients | q. s. | |||||
316 | Cilostazol Tablets IP | Each Uncoated Tablets Contains: | ||||
Cilostazol | IP | 100 mg | antiplatelet | |||
Excipients | q. s. | |||||
317 | Tadalafil Tablets IP | Each Uncoated Tablets Contains: | ||||
Tadalafil | IP | 5 mg | phosphodiesterase type 5 (PDE5) inhibitors | |||
Excipients | q. s. | |||||
318 | Tadalafil Tablets IP | Each Uncoated Tablets Contains: | ||||
Tadalafil | IP | 10 mg | phosphodiesterase type 5 (PDE5) inhibitors | |||
Excipients | q. s. | |||||
319 | Aripiprazole Tablets IP | Each Uncoated Tablets Contains: | ||||
Aripiprazole | IP | 10 mg | atypical antipsychotics | |||
Excipients | q. s. | |||||
320 | Aripiprazole Tablets IP | Each Uncoated Tablets Contains: | ||||
Aripiprazole | IP | 15 mg | atypical antipsychotics | |||
Excipients | q. s. | |||||
321 | Entecavir Tablets IP | Each Film Coated Tablets Contains: | ||||
Entecavir | IP | 1 mg | nucleoside analogs. | |||
Excipients | q. s. | |||||
322 | Entecavir Tablets IP | Each Film Coated Tablets Contains: | ||||
Entecavir | IP | 0.5 mg | nucleoside analogs. | |||
Excipients | q. s. | |||||
323 | Dnepezil hydrochloride Tablet IP | Each Film Coated Tablet Contains: | ||||
Dnepezil hydrochloride | IP | 10 mg | cholinesterase inhibitors | |||
Excipients | q. s. | |||||
324 | Labetalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains: | beta blockers | |||
Labetalol Hydrochloride | IP | 100 mg | ||||
Excipients | q. s. | |||||
325 | Labetalol Hydrochloride Tablets IP | Each Film Coated Tablet Contains: | beta blockers | |||
Labetalol Hydrochloride | IP | 200 mg | ||||
Excipients | q. s. | |||||
326 | Colchicine Tablets IP | Each Uncoated Tablet Contains: | ||||
Colchicine | IP | 0.5 mg | non-steroidal anti-inflammatory | |||
Excipients | q. s. | |||||
327 | Olanzapine Tablets IP | Each Film Coated Tablet Contains: | Atypical antipsychotic | |||
Olanzapine | IP | 10 mg | ||||
Excipients | q. s. | |||||
328 | Pirfenidone Tablets | Each Film Coated Tablet Contains: | ||||
Pirfenidone | IP | 200 mg | pyridones | |||
Excipients | q. s. | |||||
329 | Spironolactone Tablets IP | Each Uncoated Tablets Contains: | ||||
Spironolactone | IP | 25 mg | idiopathic pulmonary fibrosis | |||
Excipients | q. s. | |||||
330 | Spironolactone Tablets IP | Each Uncoated Tablets Contains: | ||||
Spironolactone | IP | 50 mg | idiopathic pulmonary fibrosis | |||
Excipients | q. s. | |||||
331 | Cefixime dispersible tablets | Each uncoated dispersible tablet contains: | ||||
Cefixime trihydrate | IP | |||||
Eq.to Anhydrous cefixime | 100mg | cephalosporin antibiotics | ||||
Excipients | q.s | |||||
Colour:Approved colour usde | ||||||
332 | Cefixime tablets | Each filmcoated dispersible tablets contains: | ||||
Cefixime Trihydrate | IP | 200mg | cephalosporin antibiotics | |||
Eq.to Anhydrous cefixime | q.s | |||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
333 | Cefixime dispersible tablets | Each uncoated dispersible tablet contains: | ||||
Cefixime trihydrate | IP | 50mg | cephalosporin antibiotics | |||
Eq.to Anhydrous cefixime | q.s | |||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
334 | Cefixime & Ofloxacin tablets | Each filmcoated dispersible tablets contains: | ||||
Cefixime trihydrate | IP | Anti-biotics | ||||
Eq.to Anhydrous cefixime | 100mg | |||||
Ofloxacin | IP | 100mg | ||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
335 | Cefixime & Ofloxacin tablets | Each filmcoated dispersible tablets contains: | ||||
Cefixime trihydrate | Anti-biotics | |||||
Eq.to Anhydrous cefixime | IP | 200mg | ||||
Ofloxacin | IP | 200mg | ||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
336 | Cefpodoxime tablet | Each filmcoated dispersible tablets contains: | ||||
Cefpodoxime proxetil | IP | 200mg | antibiotic | |||
Eq.to Cefpodoxime | q.s | |||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
337 | Cefpodoxime tablet | Each filmcoated dispersible tablets contains: | antibiotic | |||
Cefpodoxime proxetil | IP | 100mg | ||||
Eq.to Cefpodoxime | q.s | |||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
338 | Cefpoloxime | Each uncoated dispersible tablet contains: | ||||
Cefpodoxime proxetil | IP | 100mg | ||||
Eq.to Cefpodoxime | q.s | |||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
339 | Cefpodoxime dispersible tablets | Each uncoated dispersible tablet contains: | IP | 200mg | antibiotic | |
Cefpodoxime proxetil | q.s | |||||
Eq.to Cefpodoxime | ||||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
340 | Cefpoloxime &Ofloxacin tablets | Each filmcoated dispersible tablets contains: | ||||
Cefpodoxime proxetil | ||||||
Eq.to Cefpodoxime | IP | 200mg | antibiotic | |||
Ofloxacin | IP | 200mg | ||||
Excipients | q.s | |||||
Colour:Approved colour usde | ||||||
341 | Cefpodoxime &potassium clavulanate tablets | Each filmcoated dispersible tablets contains: | ||||
Cefpodoxime proxetil | IP | 200mg | antibiotic | |||
Eq.to Cefpodoxime | ||||||
Potassium clavulanate | IP | 125mg | ||||
Eq.to clavulanic Acid | ||||||
342 | Cefpodoxime &potassium clavulanate tablets | Each filmcoated dispersible tablets contains: | ||||
Cefpodoxime proxetil | IP | 100mg | antibiotic | |||
Eq.to Cefpodoxime | ||||||
Potassium clavulanate | IP | 62.5mg | ||||
Eq.to clavulanic Acid | ||||||
343 | Cefuroxime tablets | Each filmcoated dispersible tablets contains: | ||||
Cefuroxime Axetil | IP | 250mg | cephalosporin antibiotics | |||
Eq.to Cefuroxime | ||||||
Excipient | ||||||
Colour:Approved colour usde | ||||||
344 | Cefuroxime tablets | Each filmcoated dispersible tablets contains: | ||||
Cefuroxime Axetil | IP | 500mg | cephalosporin antibiotics | |||
Eq.to Cefuroxime | ||||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
345 | Cefuroxime &potassium clavulanate acid tablets | Each filmcoated dispersible tablets contains: | ||||
Cefuroxime Axetil | IP | 250mg | cephalosporin antibiotics | |||
Eq.to Cefuroxime | ||||||
Potassium clavulanate | IP | 125mg | ||||
Eq.to clavulanic Acid | ||||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
346 | Cefuroxime &potassium clavulanate acid tablets | Each filmcoated dispersible tablets contains: | ||||
Cefuroxime Axetil | IP | 500mg | antibiotic | |||
Eq.to Cefuroxime | ||||||
Potassium clavulanate | IP | 125mg | ||||
Eq.to clavulanic Acid | ||||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
347 | Cefadroxil tablets | Each filmcoated dispersible tablets contains: | ||||
Cefadroxil | IP | 500mg | antibiotic | |||
Eq.to Anhydrous cefadroxil | ||||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
348 | Sultamicillin tablets | Each film coated tablets contains: | ||||
Sultamicillin (as tosylate dihydrate) | BP | 375mg | antibiotic | |||
Eq.to sulbactum 147 mg & ampicillin 220mg ) | ||||||
Excipients | ||||||
Colour: Approved colour used | ||||||
349 | Cephalexin tablets | Each film coated tablets contains: | ||||
Contains: | IP | 250mg | cephalosporin antibiotics | |||
Eq. to Anhydrous Cephalexin | ||||||
Excipients | ||||||
Colour :Approved colour used | ||||||
350 | Amoxycillin dispersible tablets | Each uncoated dispersible tablet contains: | antibiotic | |||
Amoxycillin trihydrate | IP | 125mg | ||||
Eq.to Amoxycillin | q.s | |||||
Excipients | ||||||
Colour:Approved colour usde | ||||||
351 | Amoxycillin &Potassium clavulanate acid tablet | Each filmcoated dispersible tablets contains: | ||||
Amoxycillin trihydrate | IP | 500mg | antibiotic | |||
Eq.to Amoxycillin | ||||||
Potassium clavulanate | IP | 125mg | ||||
Eq.to clavulanic Acid | q.s | |||||
Colour :Approved colour used | ||||||
352 | Amoxycillin &Potassium clavulanate acid tablet | Each filmcoated dispersible tablets contains: | ||||
Amoxycillin trihydrate | IP | 250mg | antibiotic | |||
Eq.to Amoxycillin | ||||||
Potassium clavulanate | IP | 125mg | ||||
Eq.to clavulanic Acid | q.s | |||||
Colour:titanium dioxide IP | ||||||
353 | Amoxycillin &Potassium clavulanate acid tablet | Each filmcoated dispersible tablets contains: | ||||
Amoxycillin trihydrate | IP | 875mg | antibiotic | |||
Eq.to Amoxycillin | ||||||
Potassium clavulanate | IP | 125mg | ||||
Eq.to clavulanic Acid | q.s | |||||
Colour:titanium dioxide IP | ||||||
354 | Amoxycillin &Potassium clavulanate acid dispersible tablet | Each uncoated dispersible tablet contains: | ||||
Amoxycillin trihydrate | IP | 200mg | antibiotic | |||
Eq.to Amoxycillin | ||||||
Potassium clavulanate | IP | 28.5mg | ||||
Eq. to Clavulanic acid | q.s | |||||
Colour : Titanium Dioxide IP | ||||||
355 | Aceclofenac with Paracetamol tablets | Each film coated tablets contains: | ||||
Aceclofenac………. | IP | 100mg | anti-pyretic and analgesic | |||
Paracetamol……….. | IP | 325mg | ||||
Excipients………. | ||||||
Approved colour…..Titanium di oxide | ||||||
356 | Aceclofenac with Paracetamol tablets | Each uncoated dispersible tablet contains: | ||||
Aceclofenac………. | IP | 100mg | anti-pyretic and analgesic | |||
Paracetamol……….. | IP | 325mg | ||||
Excipients…….. | q.s | |||||
Approved colour…..Titanium di oxide Added | ||||||
357 | ofloxacin tablets | Each film coated tablets contains: | ||||
ofloxacin…… | IP | 200mg | Anti-bacterial | |||
Excipients………. | q.s | |||||
Approved colour Titanium dioxide | ||||||
358 | Azithromycin tablets | Each film coated tablets contains: | ||||
Azithromycin….. | IP | 500mg | macrolide antibiotics | |||
Excipients…….. | q.s | |||||
Approved colour……sunset Yellow | ||||||
359 | Azithromycin tablets | Each film coated tablets contains: | ||||
Azithromycin….. | IP | 250mg | macrolide antibiotics | |||
Excipients…… | q.s | |||||
Approved colour……….sunset yellow | ||||||
360 | Livocetrizine & Montelukast tablets | Each film coated tablets contains: | ||||
Livocetrizine | Anti-allgeric | |||||
Hydrochloride……….. | IP | 5mg | ||||
Montelukast…………… | IP | 10mg | ||||
Excipients……………….. | q.s | |||||
Approved colour……….Titanium di oxide | ||||||
361 | Paracetamol tablets | Each film coated tablets contains: | ||||
Paracetamol……….. | IP | 500mg | antipyretic and analgesic | |||
Excipients…………… | q.s | |||||
Approved colour…….Ttitanium di oxide | ||||||
362 | Paracetamol tablets | Each film coated tablets contains: | ||||
Paracetamol……….. | IP | 650mg | antipyretic and analgesic | |||
Excipients…………… | q.s | |||||
Approved colour…….Ttitanium di oxide | ||||||
363 | Ramipril tablets | Each uncoated dispersible tablet contains: | ACE inhibitors | |||
Ramipril | BP | 5mg | ||||
Excipients | q.s | |||||
364 | Ramipril tablets | Each uncoated dispersible tablet contains: | ||||
Ramipril | BP | 10mg | ||||
Excipients | q.s | |||||
365 | Telmisartan tablets | Each uncoated dispersible tablet contains: | ||||
Telmisartan | IP | 80mg | Hypertension | |||
Excipients | q.s | |||||
366 | Telmisartan tablets | Each uncoated dispersible tablet contains: | ||||
Telmisartan | IP | 40mg | Hypertension | |||
Excipients | q.s | |||||
367 | Glimepiride &metformin hydrochloride(sustained release tablets) | Each uncoated dispersible tablet contains: | ||||
Glimepiride | IP | 2mg | sulfonylureas | |||
metformin HCL (as sustained release form ) | IP | 500mg | ||||
Excipients | q.s | |||||
368 | Ascorbic acid tablets 100 mg | Each uncoated chewable tablets contains: | ||||
Ascorbic acid | IP | 100 mg | Vitamin | |||
Excipients | q.s | |||||
Approved colour used in tablets | ||||||
369 | Luliconazole cream | Composition | ||||
Luliconazole | IP | 1.0%W/W | antifungal | |||
Preservetive | ||||||
Benzyl alcohol | IP | 1.0%W/W | ||||
In a cream base | ||||||
370 | Rabeprazole tablets | Each enteric coated tablets contains: | proton pump inhibitors (PPIs). | |||
Rabeprazole sodium | IP | 20mg | ||||
Approved colour used | q.s | |||||
Excipients | ||||||
371 | Levocetirizine dihydrochloride tablets | Each film coated tablets contains: | Anti-allgeric | |||
Levocetirizine dihydrochloride | IP | 5mg | ||||
Excipients | q.s | |||||
colour:Approved colour usde in tablets | ||||||
372 | Nimesulide tablets | Each uncoated dispersible tablet contains: | analgesic | |||
Nimesulide | IP | 100mg | ||||
Excipients | q.s | |||||
373 | Cinnarizine & Domperidone Maleate tablets | Each uncoated dispersible tablet contains: | ||||
Cinnarizine | IP | 20mg | antiemetic | |||
Domperidone Maleate | IP | 15mg | ||||
Eq. to Domperidone | q.s | |||||
Excipients | ||||||
374 | Telmisartan & Hydrochlorothaizide tablets | Each uncoated Bilayered tablets contains: | Hypertension | |||
Telmisartan | IP | 40mg | ||||
Hydrochlorothaizide | IP | 12.5mg | ||||
Excipients | q.s | |||||
Colour :Approved colour used in tablets | ||||||
375 | Etoricoxib tablets | Each film coated tablets contains: | anti-inflammatory drugs | |||
Etoricoxib | IP | 90mg | ||||
Excipients | q.s | |||||
Approved colour used in tablets | ||||||
376 | Glimepiride tablets | Each uncotsd tablets contains: | ||||
Glimepiride | IP | 1mg | sulfonylureas | |||
Approved colour used in tablets | q.s | |||||
377 | Glimepiride tablets | Each uncotsd tablets contains: | ||||
Glimepiride | IP | 2mg | sulfonylureas | |||
Approved colour used in tablets | q.s | |||||
378 | Linezolid tablets | Each film coated tablets contains: | ||||
Linezolid | IP | 600mg | antibiotic | |||
Excipients | q.s | |||||
Approved colour used in tablets | ||||||
379 | Glicazide tablets | Each uncotsd tablets contains: | sulfonylurea | |||
Glicazide | IP | 80mg | ||||
Excipients | q.s | |||||
380 | Folic acid tablets | Each uncotsd tablets contains: | ||||
Folic acid | IP | 5mg | Vitamins, Water-Soluble. | |||
Excipients | q.s | |||||
381 | Losartan tablets | Each film coated tablets contains: | ||||
Losertan potassium | IP | 50mg | hypertension | |||
Excipients | q.s | |||||
Colour: Approved colour used | ||||||
382 | Paracetamol,Phenylephrine Hydrochloride, Ceffeine & Diphenhydramine hydrochoride Tablets | Each uncoated tablets contains: | ||||
Paracetamol | IP | 125mg | antiallergic | |||
Phenylephrine hydrochloride | IP | |||||
Caffeine (Anhydrous) | IP | 2.5mg | ||||
Diphenhydramine hydrochoride | IP | 2.5mg | ||||
Excipients | q.s | |||||
Approved colour used in tablets | ||||||
383 | Tranexamic acid &Mefenamic acid tablets | Each film coated tablets contains: | antifibrinolytics. | |||
Tranexamic acid | IP | 500mg | ||||
Mefenamic acid | IP | 250mg | ||||
Excipients | q.s | |||||
Approved colour used in tablets | ||||||
384 | Nimesulide, Phenylephrine hydrochloride & levocetirizine Dihydrochloride Tablets | Each uncoated tablets contains: | anti-inflammatory | |||
Nimesulide | BP | 100mg | ||||
Phenylephrine hydrochloride | IP | 5mg | ||||
levocetirizine Dihydrochloride | IP | 5mg | ||||
Excipients | q.s | |||||
Colour:Quinoline yellow WS | ||||||
385 | Metformin hydrochloride prolongd release and glimepiride tablets IP | Each uncoated tablets contains: | ||||
Glimepiride……………. | IP | 1mg | antidiabetic | |||
Metformin HCL ( sustained release )……………….. | IP | 500mg | ||||
Excipients…………………… | q.s | |||||
Approved colour added | ||||||
386 | Voglibose & Metformin hydrochloride (sustainrd release) tablets | Each film coated tablets contains: | Alpha glucosidase inhibitors | |||
Voglibose………. | IP | 0.3mg | ||||
Metformin HCL ( sustained release )……………….. | IP | 500mg | ||||
Excipients…………………… | q.s | |||||
387 | Voglibose & Metformin hydrochloride (sustainrd release) tablets | Each film coated tablets contains: | ||||
Voglibose………. | IP | 0.2mg | Alpha glucosidase inhibitors | |||
Metformin HCL ( sustained release )……………….. | IP | 500mg | ||||
Excipients…………………… | q.s | |||||
Approved colour added | ||||||
388 | Carbonyl iron, folic acid, vitamin B12 & zinc sulphate tablets | Each film coated tablets contains: | ||||
Carbonyl iron | IP | 100mg | Vitamins | |||
Eq.to elemental iron | ||||||
Folic acid | IP | 1.5mg | ||||
Vitamin B12 | IP | 15mg | ||||
Zinc sulphate monohydrate | IP | 22.5mg | ||||
Excipients | q.s | |||||
Approbved colour used in tablets | ||||||
389 | Thiamine hydrochloride tablets 100 mg | Each film coated tablets contains: | ||||
Thiamine hydrochloride | IP | 100mg | Vitamins b1 | |||
Excipients | q.s | |||||
Approbved colour used in tablets | ||||||
390 | Ferrous Ascorbate, Folic Acid, Cyanocobalamin & Zinc Sulphate Tablets | Each film coated tablets contains: | ||||
Ferrous ascorbate | ||||||
Eq.to elemental iron | IP | 100mg | Vitamins | |||
Folic acid | IP | 1.5mg | ||||
Cyanocobalamin triturate | ||||||
Eq.to Cyanocobalamin | IP | 7.5mg | ||||
Zinc sulphate monohydrate | IP | 22.5mg | ||||
Eq.to elemental zinc | ||||||
Excipients | q.s | |||||
Approbved colour used in tablets | ||||||
391 | Aceclofenac Sustained Release Tablets IP | Each uncoated Sustained release tablet contains: | anti-inflammatory drugs | |||
Aceclofenac | IP | 200mg | ||||
Excipients | ||||||
392 | Aceclofenac & Diacerin Tablet | Each filmcoated tablet contains: | ||||
Aceclofenac | IP | 100mg | anti-inflammatory drugs | |||
Diacerin | IP | 80mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
393 | Doxofylline Tablets IP | Each uncoated tablet contain: | ||||
Doxofyllin | IP | 400mg | xanthine derivative drug (asthma) | |||
Excipients | ||||||
394 | Methylcobalamin Tablet IP | Each filmcoated tablet contains: | ||||
Methylcobalamin | IP | 500mcg | Vitamins | |||
Excipients | ||||||
395 | Dosulepin tablets IP | Each filmcoated tablet contains: | ||||
Dosulepin Hydrochloride | IP | 100mg | ||||
Excipients | ||||||
396 | Ferrous Ascorbate, folic acid, Zinc Sulphate & cyanocobalamin tablets | Each filmcoated tablet contains: | Vitamins | |||
Ferrous Ascorbate | ||||||
Eq. to Elemental Iron | 100mg | |||||
folic acid | IP | 1.5mg | ||||
Zinc sulphate Monohydrate | IP | 61.8mg | ||||
Eq. to. Elemental Zinc | ||||||
cyanocobalamin | 22.5mg | |||||
Excipients | 15 mcg | |||||
Colour: Approved colour used | ||||||
397 | Drotravarine & Aceclofenac Tablets | Each filmcoated tablet contains: | ||||
Drotravarine hydrochloride | IP | anti-inflammatory drug | ||||
Eq. to.Drotravarine | 50mg | |||||
Aceclofenac | IP | 100mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
398 | Fexofinadine & Montelukast Chewable Tablets | Each uncoated tablet contain: | ||||
Fexofinadine HCL | IP | 120mg | antihistamines | |||
Montelukast Sodium | IP | |||||
Eq. to. Montelukast | 10mg | |||||
399 | Voglibose & Metformin HCL Tablets | Each uncoated tablet contain: | ||||
Voglibose | IP | 0.2mg | antidiabetic | |||
Metformin HCL | IP | 500mg | ||||
Excipients | ||||||
400 | Calcium citrate Maleate, Vitamin D3 With folic Acid tablets | Each uncoated tablet contain: | ||||
Calcium citrate Maleate | ||||||
Eq. to. Elemental calcium | 250mg | Vitamins | ||||
Vitamin D3 | IP | 100IU | ||||
folic Acid | IP | 50mcg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
401 | Diclofenac sodium and Serratiopeptidase Tablets | Each enteric coated tablet contain: | ||||
Diclofenac sodium | IP | 50mg | NSAID | |||
Serratiopeptidase | IP | 10mg | ||||
Excipients | q.s | |||||
Colour: Approved colour used | ||||||
402 | Calcium citrate , Calcitriol, Zinc sulphate monohydrate & Manganese Tablets | Each filmcoated tablet contains: | ||||
Calcium citrate | USP | 1000mcg | (osteoporosis), weak bones (osteomalacia/rickets) | |||
Calcitriol | BP | 0.25mcg | ||||
Zinc sulphate monohydrate | ||||||
Eq. to. Elemental Zinc | 7.5mg | |||||
Manganese sulphate | IP | |||||
Eq. to. Manganese | 40mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
403 | Doxofylline Tablets IP | Each filmcoated tablet contains: | xanthine derivative drug | |||
Doxofylline | IP | 400mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
404 | Ciprofloxacin and Tinidazole Tablets | Each filmcoated tablet contains: | ||||
Ciprofloxacin HCL | IP | antibiotics | ||||
Eq. to. Ciprofloxaxin | 500mg | |||||
Tinidazole | IP | 600mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
405 | Tranexamic Acid & Ethamsylate Tablets | Each filmcoated tablet contains: | anti-fibrinolytic agents' | |||
Tranexamic Acid | BP | 250mg | ||||
Ethamsylate | BP | 250mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
406 | Aceclofenac Tablet IP | Each filmcoated tablet contains: | ||||
Aceclofenac | IP | 100mg | inflammatory | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
407 | Pantoprazole and Domperidone tablets | Each enteric coated tablet contain: | Proton- pump inhibitor | |||
Pantoprazole sodium | IP | 40mg | ||||
Eq. to. Pantaprozole | 10mg | |||||
Domperidone | IP | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
408 | Doxofylline & Ambroxol HCL Tablets | Each filmcoated tablet contains: | ||||
Doxofylline | IP | 400mg | xanthine derivative drug | |||
Ambroxol HCL | IP | 30mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
409 | Ivermectin Tablets | Each uncoated tablet contain: | anthelmintics | |||
Ivermectin | IP | 6mg | ||||
Excipients | ||||||
410 | Ondansetron Orally Disentegratinf Tablets IP | Each Orally Disentegrating tablets contain: | ||||
Ondansetron HCL | IP | serotonin 5-HT3 receptor antagonists | ||||
Eq. to. Ondansetron | 4mg | |||||
Excipients | ||||||
411 | Ezetimibe & Simvastatin Tablets | Each filmcoated tablet contains: | ||||
Ezetimibe | IP | 10mg | statins | |||
Simvastatin | IP | 20mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
412 | Nateglinide & Metformin HCL (SR) Tablets | Each uncoated tablet contain: | ||||
Nateglinide | IP | 600mg | meglitinides | |||
Metformin HCL | IP | 500mg | ||||
As sustained release | ||||||
Excipients | ||||||
413 | Nateglinide & Metformin HCL (SR) Tablets | Each uncoated tablet contain: | ||||
Nateglinide | IP | 120mg | meglitinides | |||
Metformin HCL | IP | 500mg | ||||
As sustained release | ||||||
Excipients | ||||||
414 | Thicolchicoside & Ketoprofen Tablet | Each filmcoated tablet contains: | ||||
Thicolchicoside | IP | 4mg | NSAIDs. | |||
Ketoprofen | IP | 50mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
415 | Thicolchicoside & Ketoprofen Tablet | Each filmcoated tablet contains: | ||||
Thicolchicoside | IP | 8mg | NSAIDs. | |||
Ketoprofen | IP | 100mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
416 | Hyoscine Butylbromide Tablets IP | Each filmcoated tablet contains: | ||||
Hyoscine Butylbromide | IP | 10mg | anticholinergic drug | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
417 | Atorvastatin & Nicotinic Acid (ER) tablet | Each filmcoated tablet contains: | ||||
Atorvastatin calcium | IP | antilipemic agents | ||||
Eq. to atorvastatin | 10mg | |||||
Nicotinic Acid | IP | 375mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
418 | Atorvastatin & Nicotinic Acid (ER) tablet | Each filmcoated tablet contains: | ||||
Atorvastatin calcium | IP | antilipemic agents | ||||
Eq. to atorvastatin | 10mg | |||||
Nicotinic Acid | IP | 500mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
419 | Amlodipine Hydrochlorthazide Tablet | Each filmcoated tablet contains: | calcium channel blockers | |||
Amlodipine Besylate | IP | |||||
Eq. to.Amlodipine | 5mg | |||||
Hydrochlorthazide | IP | 12.5mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
420 | Amlodipine Hydrochlorthazide Tablet | Each filmcoated tablet contains: | ||||
Amlodipine Besylate | IP | calcium channel blockers | ||||
Eq. to.Amlodipine | 2.5mg | |||||
Hydrochlorthazide | IP | 12.5mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
421 | Cefpodoxime & ofloxacin Tablet | Each filmcoated tablet contains: | ||||
Cefpodoxime proxetil | IP | cephalosporin antibiotics. | ||||
Eq. to. Cefpodoxime | 200mg | |||||
ofloxacin | IP | 200mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
422 | Aceclofenac & Thiocolchicoside Tablet | Each filmcoated tablet contains: | ||||
Aceclofenac | IP | 100mg | anti-inflammatory drug (NSAID) | |||
Thiocolchicoside | IP | 8mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
423 | Nimesulide Phenylephlephrine Hydrochloride, Levocetirizine Hydrochloride Tablets | Each uncoated tablet contains: | anti-inflammatory drug (NSAID) | |||
Nimesulide | BP | 100mg | ||||
Phenylephlephrine | IP | 5mg | ||||
Hydrochloride | ||||||
Levocetirizine Hydrochloride | IP | 5mg | ||||
Excipients | ||||||
424 | Paracetamol, Phenylephrine Hydrochloride & caffeine Tablet | Each uncoated tablet contains: | ||||
Paracetamol | IP | 500mg | ||||
caffeine Anhydrous | IP | 32mg | Anti-allgeric | |||
Phenylephrine Hydrochloride | IP | 10mg | ||||
Excipients | ||||||
425 | Paracetamol, Phenylephrine Hydrochloride Diphenhydramine Hyrochloride Caffeine Tablet | Each uncoated tablet contains: | ||||
Paracetamol | IP | 500mg | Anti-allgeric | |||
Phenylephrine | IP | 5mg | ||||
Hydrochloride Diphenhydramine Hyrochloride | IP | 25mg | ||||
Caffeine | IP | 30mg | ||||
Excipients | ||||||
426 | Lansoprazole orally Disintegration Tablet | Each uncoated tablet contains: | ||||
Lansoprazole | IP | 30mg | proton pump inhibitors. | |||
(as entric coated pellets) | ||||||
Excipients | q.s | |||||
427 | Mefenamic Acid & Dicyclomine Hydrochloride Tablet IP | Each uncoated tablet contains: | ||||
Mefenamic Acid | IP | 250mg | analgesic, anti-inflammatory | |||
Dicyclomine Hydrochloride | IP | 10 mg | ||||
Excipients | ||||||
428 | Paracetamol, Levocetirizine Hydrochloride & Phenylephrine Hydrochloride Tablet | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325mg | antiallergic | |||
Levocetirizine Hydrochloride | IP | 5mg | ||||
Phenylephrine Hydrochloride | IP | 5mg | ||||
Excipients | ||||||
429 | Paracetamol , Phenylephrine Hydrochloride & Cetirizine Tablet | Each uncoated tablet contains: | ||||
Paracetamol | IP | 500mg | Anti-allgeric | |||
Phenylephrine Hydrochloride | IP | 10mg | ||||
Cetirizine hydrochloride | IP | 5mg | ||||
Excipients | ||||||
430 | Paracetamol , Phenylephrine Hydrochloride , Chlorpheniramines Maleate & Caffeine Tablet | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325mg | Anti-allgeric | |||
Phenylephrine Hydrochloride | IP | 10mg | ||||
Chlorpheniramines Maleate | IP | 2mg | ||||
Caffeine | IP | 30mg | ||||
Excipients | ||||||
431 | Paracetamol, levocetirizine Hydrochloride & Phenylephrine Hydrochloride Tablet | Each uncoated tablet contains: | ||||
Paracetamol | IP | 500mg | Anti-allgeric | |||
levocetirizine Hydrochloride | IP | 5mg | ||||
Phenylephrine Hydrochloride | IP | 5mg | ||||
Excipients | ||||||
432 | Trypsin Bromelain Rutoside Tablet | Each enteric coated tablet contain: | ||||
Trypsin | IP | 96mg | anti-inflammatory | |||
Bromelain | IP | 180mg | ||||
Rutoside trihydrate | IP | 200mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
433 | Rifaximin Tablet | Each filmcoated tablet contains: | ||||
Rifaximin PH Eur | 400mg | antibiotics | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
434 | Rifaximin Tablet | Each filmcoated tablet contains: | ||||
Rifaximin PH Eur | 400mg | antibiotics | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
435 | Rifaximin Tablet | Each filmcoated tablet contains: | antibiotics | |||
Rifaximin PH Eur | 550mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
436 | Clarithromycin Tablet IP | Each filmcoated tablet contains: | ||||
Clarithromycin | IP | 500mg | Antibiotic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
437 | Clarithromycin Tablet IP | Each filmcoated tablet contains: | ||||
Clarithromycin | IP | 250mg | Antibiotic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
438 | Etoricoxib Tablet IP | Each filmcoated tablet contains: | ||||
Etoricoxib | IP | 60mg | anti-inflammatory drug. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
439 | Etoricoxib Tablet IP | Each filmcoated tablet contains: | ||||
Etoricoxib | IP | 90mg | anti-inflammatory drug. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
440 | Albendazole Tablet | Each uncoated tablet contains: | ||||
Albendazole | IP | 400mg | antihelmintics | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
441 | Citicoline& Piracitam Tablets | Each filmcoated tablet contains: | CDP-choline; cytidine 5'-diphosphocholine | |||
Citicoline Sodium | IP | |||||
Eq. to.Citicoline | 500mg | |||||
piracitam | IP | 800mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
442 | Cefixime & Ornidazole Tablet | Each filmcoated tablet contains: | antibiotic | |||
Cefixime Trihydrate | IP | |||||
Eq. to Cefixime | 100mg | |||||
Ornidazole | IP | 500mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
443 | Bromhexin HCL, Chlorpheniramine Maleate , Terbutaline Sulphate Tablets | Each uncoated tablet contains: | ||||
Bromhexin HCL | IP | 16mg | 0 | |||
Chlorpheniramine Maleate | IP | 4mg | ||||
Terbutaline Sulphate | IP | 2.5mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
444 | Clopidogrel Tablet IP | Each filmcoated tablet contains: | ||||
Clopidogrel Bisulphate | IP | Thienopyridine | ||||
Eq. to.Clopidogrel | 75mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
445 | Clopidogrel & Aspirin Tablet IP | Each filmcoated tablet contains: | ||||
Clopidogrel Bisulphate | IP | Thienopyridine | ||||
Eq. to.Clopidogrel | 75mg | |||||
Aspirin | IP | 75mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
446 | Clopidogrel & Aspirin Tablet IP | |||||
Each filmcoated tablet contains: | Thienopyridine | |||||
Clopidogrel Bisulphate | IP | |||||
Eq. to.Clopidogrel | 75mg | |||||
Aspirin | IP | 150mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
447 | Losartan Potassium & Hydrochlorothiazide Tablet IP | Each filmcoated tablet contains: | ||||
Losartan Potassium | IP | 50mg | hypertension | |||
Hydrochlorothiazide | IP | 212.5mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
448 | Losartan Potassium | Each filmcoated tablet contains: | ||||
Losartan Potassium | IP | 50mg | hypertension | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
449 | Losartan Potassium | Each filmcoated tablet contains: | ||||
Losartan Potassium | IP | 25mg | hypertension | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
450 | Paracetamiol Tablet IP | Each uncoated tablet contains: | ||||
Paracetamiol | IP | 500mg | analgesics | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
451 | Paracetamiol Tablet IP | Each uncoated tablet contains: | ||||
Paracetamiol | IP | 650mg | analgesics | |||
Excipients | ||||||
452 | Paracetamol & Caffeine Tablet IP | Each uncoated tablet contains: | ||||
Paracetamol | IP | 650mg | analgesic and antipyretic | |||
Caffeine (Anhydrous) | IP | 25mg | ||||
Excipients | q.s | |||||
453 | Paracetamol & Caffeine Tablet IP | Each uncoated tablet contains: | ||||
Paracetamol | IP | 500mg | analgesic and antipyretic | |||
Caffeine (Anhydrous) | IP | 25mg | ||||
Excipients | q.s | |||||
454 | Folic Acid Tablets | Each uncoated tablet contains: | ||||
Folic Acid | IP | 10mg | ||||
Excipients | ||||||
455 | Folic Acid & Methylcobalamin Tablets | Each uncoated tablet contains: | ||||
folic Acid | IP | 5mg | vitamin | |||
Methylcobalamin | IP | 750mg | ||||
Excipients | ||||||
456 | Paracetamol & Ibuprofen Tablet IP | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325mg | analgesic and antipyretic | |||
Ibuprofen | IP | 400mg | ||||
Excipients | ||||||
457 | Cholecalciferol chewable Tablet 60000 IU | Each uncoated tablet contains: | ||||
Cholecalciferol | IP | 60000IU | vitamin | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
458 | Tadalafil Tablet | Each filmcoated tablet contains: | ||||
Tadalafil | IP | 20mg | phosphodiesterase (PDE) inhibitors. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
459 | Piracetam Tablet | Each filmcoated tablet contains: | ||||
Piracetam | IP | 800mg | antipsychotic drugs | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
460 | Fluconazole Tablet | Each uncoated tablet contains: | Anti-fungal | |||
Fluconazole | IP | 200mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
461 | Norfloxacin & Tinidazolre Tablet | Each filmcoated tablet contains: | ||||
Norfloxacin | IP | 400mg | antibacterials. | |||
Tinidazolre | IP | 600mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
462 | Primaquine Tablet IP | Each filmcoated tablet contains: | antimalarials. | |||
Primaquine Phosphate | IP | |||||
Eq. to. Primaquine | 7.5mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
463 | Primaquine Tablet IP | Each filmcoated tablet contains: | ||||
Primaquine Phosphate | IP | |||||
Eq. to. Primaquine | 15mg | antimalarials. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
464 | Acyclovir Tablets | Each uncoated tablet contains: | ||||
Acyclovir | IP | 200mg | Anti-viral | |||
Excipients | ||||||
465 | Acyclovir Tablets | Each uncoated tablet contains: | ||||
Acyclovir | IP | 400mg | Anti-viral | |||
Excipients | ||||||
466 | Acyclovir Tablets | Each uncoated tablet contains: | ||||
Acyclovir | IP | 800mg | Anti-viral | |||
Excipients | ||||||
467 | Thicolchicoside Tablet | Each filmcoated tablet contains: | ||||
Thicolchicoside | IP | 4mg | anti-inflammatory and analgesic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
468 | Fluconazole Tablet IP | Each uncoated tablet contains: | ||||
Fluconazole | IP | 150mg | Anti-fungal | |||
Excipients | ||||||
469 | Citirizine tablets IP | Each filmcoated tablet contains: | ||||
Citirizine Dihydrochloride | IP | 10mg | Anti-allgeric | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
470 | Atorvastatin & Amlodipine tablet | Each filmcoated tablet contains: | ||||
Atorvastatin calcium | IP | statins | ||||
Eq. to.Atorvastatin | 10mg | |||||
Amlodipine Besylate | IP | |||||
Eq. to. Amlodipine | 5mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
471 | Atorvastatin & Amlodipine tablet | Each filmcoated tablet contains: | ||||
Atorvastatin calcium | IP | statins | ||||
Eq. to.Atorvastatin | 20mg | |||||
Amlodipine Besylate | IP | |||||
Eq. to. Amlodipine | 5mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
472 | Atorvastatin & Amlodipine tablet | Each filmcoated tablet contains: | ||||
Atorvastatin calcium | IP | statins | ||||
Eq. to.Atorvastatin | 40mg | |||||
Amlodipine Besylate | IP | |||||
Eq. to. Amlodipine | 10mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
473 | Minocycline Tablet USP | Each filmcoated tablet contains: | antibiotic | |||
Minocycline hydrochloride | USP | |||||
Eq.to.Minocycline | 100mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
474 | Minocycline Tablet USP | Each filmcoated tablet contains: | ||||
Minocycline hydrochloride | USP | antibiotic | ||||
Eq.to.Minocycline | 50mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
475 | Artemether & Lumefantrine Dispersible Tablets | Each uncoated tablet contains: | ||||
Artemether | IP | 20mg | Anti-malaria. | |||
Lumefantrine | USP | 120mg | ||||
Excipients | ||||||
476 | Artemether & Lumefantrine Dispersible Tablets | Each uncoated tablet contains: | ||||
Artemether | IP | 80mg | Anti-malaria. | |||
Lumefantrine | USP | 480mg | ||||
Excipients | ||||||
477 | Levetiracetam Tablets | Each uncoated tablet contains: | ||||
Levetiracetam | IP | 500mg | anticonvulsants | |||
Excipients | ||||||
478 | Levetiracetam Tablets | Each uncoated tablet contains: | ||||
Levetiracetam | IP | 750mg | anticonvulsants | |||
Excipients | ||||||
479 | Hydroxychloroquine Tablets IP 200mg | Each filmcoated tablet contains: | ||||
Hydroxychloroquine Sulphate | IP | 200Mmg | antimalarials. | |||
Colour: Approved colour used | ||||||
480 | Hydroxychloroquine Tablets IP 400mg | Each filmcoated tablet contains: | ||||
Hydroxychloroquine Sulphate | IP | 400mg | antimalarials. | |||
Colour: Approved colour used | ||||||
481 | Ondansetron Orally Disentegratinf Tablets IP | Each orally Disentegrating tablets contain: | ||||
Ondansetron HCL | IP | |||||
Eq. to.Ondansetron | 8Mmg | 5-HT3 antagonist | ||||
Excipients | ||||||
482 | Levocetirizine HCL Tablets | Each filmcoated tablet contains: | ||||
Levocetirizine HCL | IP | 10mg | Anti-allgeric | |||
Excipients | ||||||
483 | Nimesulide & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Nimesulide | IP | 100mg | Anti-pyretic /analgesic | |||
Paracetamol | IP | 325mg | ||||
484 | Ivermectin Tablets IP | Each uncoated tablet contains: | ||||
Ivermectin | IP | 12mg | anthelmintics | |||
Excipients | q.s | |||||
485 | Enalapril Meleate Tablet IP | Each uncoated tablet contains: | ||||
Enalapril Meleate | IP | 2.5mg | angiotensin-converting enzyme (ACE) inhibitors. | |||
Excipients | ||||||
486 | Enalapril Meleate Tablet IP | Each uncoated tablet contains: | ||||
Enalapril Meleate | IP | 5mg | angiotensin-converting enzyme (ACE) inhibitors. | |||
Excipients | ||||||
487 | Atorvastatin & Ezetemibe tablet | Each filmcoated tablet contains: | ||||
Atorvastatin calcium | IP | |||||
Eq. to. Atorvastatin | 10mg | statins | ||||
Ezetemibe | 10mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
488 | Indapamide Tablets IP | Each filmcoated tablet contains: | ||||
Indapamide | IP | 2.5mg | diuretics | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
489 | Terazocin HCL Tablet | Each uncoated tablet contains: | ||||
Terazocin HCL | IP | |||||
Eq. to Terazocin | 1mg | alpha-blockers | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
490 | Terazocin HCL Tablet | Each uncoated tablet contains: | ||||
Terazocin HCL | IP | alpha-blockers | ||||
Eq. to Terazocin | 2mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
491 | Levofloxacin Tablet IP | Each filmcoated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | Anti-bacterial | ||||
Eq. to Levofloxacin | 500mg | |||||
Excipients | ||||||
492 | Pioglitazone HCL Tablet IP | Each uncoated tablet contains: | anti-diabetic | |||
Pioglitazone HCL | IP | |||||
Eq. to Pioglitazone | 15mg | |||||
Excipients | ||||||
493 | Pioglitazone HCL Tablet IP | Each uncoated tablet contains: | ||||
Pioglitazone HCL | IP | anti-diabetic | ||||
Eq. to Pioglitazone | 30mg | |||||
Excipients | ||||||
494 | Fexofenadine HCL Tablet IP | Each uncoated tablet contains: | ||||
Fexofenadine HCL | IP | 120mg | antihistamines | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
495 | Fexofenadine HCL Tablet IP | Each uncoated tablet contains: | ||||
Fexofenadine HCL | IP | 180mg | antihistamines | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
496 | Ivermectin Tablets | Each filmcoated tablet contains: | anthelmintics | |||
Ivermectin | IP | 6mg | ||||
Excipients | ||||||
497 | Hydroxychloroquine Sulphate Tablet IP | Each filmcoated tablet contains: | ||||
Hydroxychloroquine Sulphate | IP | 200mg | antimalarials. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
498 | Clarithromycin Tablet IP | Each filmcoated tablet contains: | ||||
Clarithromycin | IP | 250mg | Antibiotic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
499 | Montelukast Tablet IP | Each filmcoated tablet contains: | ||||
Montelukast Sodium | IP | |||||
Eq. to Montelukast | 5mg | leukotriene receptor antagonists (LTRAs) | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
500 | Montelukast Tablet IP | Each filmcoated tablet contains: | ||||
Montelukast Sodium | IP | |||||
Eq. to Montelukast | 10mg | leukotriene receptor antagonists (LTRAs) | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
501 | Levocetirizine Tablets IP | Each uncoated tablet contains: | ||||
Levocetirizine Dihydrochloride | IP | 5mg | ||||
Excipients | Anti-allgeric | |||||
502 | Prasugrel Tablet | Each filmcoated tablet contains: | ||||
Prasugrel hydrochloride | ||||||
Eq to Prasugrel | 5mg | anti-platelet | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
503 | Prasugrel Tablet | Each filmcoated tablet contains: | ||||
Prasugrel hydrochloride | ||||||
Eq to Prasugrel | 10mg | anti-platelet | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
504 | Entecavir Tablet | Each filmcoated tablet contains: | ||||
Entecavir | 0.5mg | antiviral | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
506 | Entecavir Tablet | Each filmcoated tablet contains: | ||||
Entecavir | 10mg | antiviral | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
507 | Lamivudine Tablet IP | Each filmcoated tablet contains: | ||||
Lamivudine | IP | 150mg | nucleoside reverse transcriptase inhibitors (NRTIs) | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
508 | Nevirapine Tablet IP | Each uncoated tablet contains: | ||||
Nevirapine | IP | 200mg | (NNRTIs) | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
509 | Efavirenz Tablet IP | Each uncoated tablet contains: | ||||
Efavirenz | IP | 600mg | non-nucleoside reverse transcriptase inhibitors (NNRTIs). | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
510 | Zidovudine Tablet IP | Each filmcoated tablet contains: | ||||
Zidovudine | IP | 300mg | nucleoside reverse transcriptase inhibitors-NRTIs | |||
Excipients | ||||||
511 | Abacavir Tablet IP | Each filmcoated tablet contains: | ||||
Abacavir | IP | 300mg | nucleoside reverse transcriptase inhibitors (NRTIs). | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
512 | Ropinirole Tablet IP | Each filmcoated tablet contains: | ||||
Ropinirole Hydrochloride | IP | |||||
Eq. to Ropinirole | 0.25mg | Parkinson's disease and Restless Legs Syndrome.04-Aug-2017 | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
513 | Ropinirole Tablet IP | Each filmcoated tablet contains: | ||||
Ropinirole Hydrochloride | IP | Parkinson's disease and Restless Legs Syndrome.04-Aug-2017 | ||||
Eq. to Ropinirole | 0.5mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
514 | Tenofovir disoproxil Fumarate & Emtricitabine Tablet IP | Tenofovir disoproxil Fumarate | IP | 300mg | control HIV infection | |
Emtricitabine | IP | 200mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
515 | Stavudine , Lamivudine and Nevirapine Tablet IP | Each uncoated tablet contains: | ||||
Stavudine | IP | 30mg | nucleoside reverse transcriptase inhibitors-NRTIs | |||
Lamivudine | IP | 150mg | ||||
Nevirapine | IP | 200mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
516 | Zidovudine, lamivudine and nevirapine Tablet IP | Each filmcoated tablet contains: | ||||
Zidovudine | IP | 300mg | nucleoside reverse transcriptase inhibitors-NRTIs | |||
Lamivudine | IP | 150mg | ||||
Nevirapine | IP | 200mg | ||||
Colour: Approved colour used | ||||||
517 | Lopinavir and Ritonavir Tablet IP | Each filmcoated tablet contains: | ||||
Lopinavir | IP | 200mg | control HIV infection | |||
Ritonavir | IP | 50mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
518 | Lamivudine and Tenofovir disoproxil fumarate Tablet IP | Each filmcoated tablet contains: | ||||
Lamivudine | IP | 300mg | nucleoside reverse transcriptase inhibitors-NRTIs | |||
Tenofovir disoproxil fumarate | IP | 300mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
519 | Divalproex Sodium Tablet IP | Each filmcoated tablet contains: | ||||
Divalproex Sodium | IP | 250mg | anti-epileptics. | |||
Eq. to Valporic Acid | ||||||
Excipients | ||||||
Colour: Approved colour used | ||||||
520 | Divalproex Sodium Tablet IP | Each filmcoated tablet contains: | ||||
Divalproex Sodium | IP | 500mg | anti-epileptics. | |||
Eq. to Valporic Acid | ||||||
Excipients | ||||||
Colour: Approved colour used | ||||||
521 | Trioxsalen Tablet USP | Each filmcoated tablet contains: | ||||
Trioxsalen | IP | 5mg | to treat vitiligo | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
522 | Trioxsalen Tablet USP | Each filmcoated tablet contains: | ||||
Trioxsalen | IP | 25mg | to treat vitiligo | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
523 | Sevelamer HCL Tablet | Each filmcoated tablet contains: | ||||
Sevelamer HCL | 400mg | hyperphosphatemia | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
524 | Ivabradine HCL Tablet | Each filmcoated tablet contains: | ||||
Ivabradine HCL | 5mg | hyperpolarization-activated cyclic nucleotide-gated (HCN) channel blockers | ||||
Eq. to Ivabradine | ||||||
Excipients | ||||||
Colour: Approved colour used | ||||||
525 | Montelukast Sodium and Levocetirizine Dihydrochloride Dispersible Tablet | Each filmcoated tablet contains: | Anti- allgeric | |||
Montelukast Sodium | IP | |||||
EQ. to Montelukast | 5mg | |||||
Levocetirizine Dihydrochloride | IP | 2.5mg | ||||
Excipients | ||||||
526 | Rasagiline Tablet | Each filmcoated tablet contains: | ||||
Rasagiline Mesylate | 0.5mg | Parkinson's disease | ||||
Eq .to Rasagiline | ||||||
Excipients | ||||||
527 | Doxophylline (sustained Release) and Montelukast Tablet | Each uncoated tablet contains: | ||||
Doxophylline(sustained Release) | IP | 400mg | ||||
Montelukast sodium | IP | 10mg | Anti-allergies | |||
Eq to Montelukast | ||||||
Excipients | ||||||
528 | Hyoscine Butylbromide Tablets IP | Each filmcoated tablet contains: | ||||
Hyoscine Butylbromide | IP | 10mg | anticholinergic drug | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
529 | Tolperisone HCL Tablet | Each uncoated tablet contains: | ||||
Tolperisone HCL | 100mg | neurological diseases | ||||
Excipients | ||||||
530 | Clonidine Tablet IP | Each uncoated tablet contains: | ||||
Clonidine | IP | 100mcg | antihypertensive | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
531 | Mycophenol mofetil Tablet USP | Each filmcoated tablet contains: | ||||
Mycophenol mofetil | 250mg | immunosuppressants. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
532 | Mycophenol mofetil Tablet USP | Each filmcoated tablet contains: | ||||
Mycophenol mofetil | 500mg | immunosuppressants. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
533 | Risperidone Tablet IP | Each filmcoated tablet contains: | ||||
Risperidone | IP | 3mg | Atypical antipsychotic | |||
Excipients | ||||||
534 | Risperidone Tablet IP | Each filmcoated tablet contains: | ||||
Risperidone | IP | 4mg | Atypical antipsychotic | |||
Excipients | ||||||
535 | Procycline HCL Tablet IP | Each uncoated tablet contains: | ||||
Procycline HCL | IP | 2.5mg | Atypical antipsychotic | |||
Excipients | ||||||
536 | Procycline HCL Tablet IP | |||||
Each uncoated tablet contains: | Atypical antipsychotic | |||||
Procycline HCL | IP | 5mg | ||||
Excipients | ||||||
537 | Ethambutol Tablet IP | Each filmcoated tablet contains: | ||||
Ethambutol | IP | 200mg | antibiotic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
538 | Etoricoxib Tablet IP | Each filmcoated tablet contains: | ||||
Etoricoxib | IP | 120mg | anti-inflammatory | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
539 | Prazosin HCL Tablet | Each filmcoated sustain release tablet contains: | ||||
Prazosin HCL | IP | alpha-blockers | ||||
Eq .to Prazosin HCL | 5mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
540 | Diltiazem HCL Tablet | Each filmcoated tablet contains: | ||||
Diltiazem HCL | IP | 60mg | calcium-channel blockers | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
541 | Diltiazem HCL Tablet | Each filmcoated tablet contains: | ||||
Diltiazem HCL | IP | 30 mg | calcium-channel blockers | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
542 | Nebivilol HCL Tablet IP | Each uncoated tablet contains: | ||||
Nebivilol HCL | IP | |||||
Eq to Nebivilol | 5mg | beta blockers | ||||
Excipients | ||||||
543 | Ciprofloxacin and Tinidazole Tablet | Each uncoated tablet contains: | ||||
Ciprofloxacin | IP | 500mg | antibiotics | |||
Tinidazole | IP | 600mg | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
544 | Ezetimibe Tablet IP | Each uncoated tablet contains: | ||||
Ezetimibe | IP | 10mg | cholesterol-lowering medications | |||
Excipients | ||||||
545 | Deflazacort Tablet | Each uncoated tablet contains: | ||||
Deflazacort | IP | 18mg | corticosteroids | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
546 | Torsemide Tablet IP | Each uncoated tablet contains: | ||||
Torsemide | IP | 20mg | diuretics | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
547 | Valsartan Tablet IP | Each filmcoated tablet contains: | ||||
Valsartan | IP | 40mg | angiotensin receptor blockers | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
548 | Valsartan Tablet IP | Each filmcoated tablet contains: | ||||
Valsartan | IP | 80mg | angiotensin receptor blockers | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
549 | Nicoumalone Tablet IP | Each uncoated tablet contains: | ||||
Nicoumalone | IP | 2mg | anticoagulants. | |||
Excipients | ||||||
550 | Nicoumalone Tablet IP | Each uncoated tablet contains: | ||||
Nicoumalone | IP | 4mg | anticoagulants. | |||
Excipients | ||||||
551 | Olanzapine Tablet IP | Each filmcoated tablet contains: | ||||
Olanzapine | IP | 10mg | atypical antipsychotics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
552 | Trihexyphenidyl hydrochloride Tablet IP | Each uncoated tablet contains: | ||||
Trihexyphenidyl hydrochloride | IP | 2mg | anticholinergics | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
553 | Nortriptyline Hydrochloride Tablet IP | Each uncoated tablet contains: | ||||
Nortriptyline Hydrochloride | IP | |||||
Eq. to Nortriptyline | 25mg | tricyclic antidepressants | ||||
Excipients | ||||||
554 | Colour: Approved colour used | |||||
Frusemide and Spironolactone Tablet | Each filmcoated tablet contains: | |||||
Frusemide | IP | 20mg | aldosterone receptor antagonists | |||
Spironolactone | IP | 50mg | ||||
Excipients | ||||||
555 | Colour: Approved colour used | |||||
Propranolol Tablet IP | Each Uncoated tablet contains: | |||||
Propranolol HCL | IP | 40mg | beta blockers | |||
556 | Excipients | |||||
Repaglinide Tablet IP | Each Uncoated tablet contains: | |||||
Repaglinide | IP | 0.5mg | antidiabetic | |||
Excipients | ||||||
557 | Repaglinide Tablet IP | Each Uncoated tablet contains: | ||||
Repaglinide | IP | 1mg | antidiabetic | |||
Excipients | ||||||
558 | Repaglinide Tablet IP | Each Uncoated tablet contains: | ||||
Repaglinide | IP | 2mg | antidiabetic | |||
Excipients | ||||||
559 | Hydrochlorothiazide Tablet IP | Each Uncoated tablet contains: | ||||
Hydrochlorothiazide | IP | 12.5mg | diuretics/"water pills | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
560 | Fenofibrate Tablet | Each filmcoated tablet contains: | ||||
Fenofibrate | IP | 160mg | Fibric Acid Agents | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
561 | Donepezil hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Donepezil hydrochloride | IP | 10mg | Acetylcholinesterase inhibitor | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
562 | Donepezil hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Donepezil hydrochloride | IP | 5mg | Acetylcholinesterase inhibitor | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
563 | Solifenacin Tablet IP | Each filmcoated tablet contains: | ||||
Solifenacin succinate | IP | 5mg | antimuscarinics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
564 | Solifenacin Tablet IP | Each filmcoated tablet contains: | ||||
Solifenacin succinate | IP | 10mg | antimuscarinics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
565 | Bisoprolol Fumarate Tablet USP | Each filmcoated tablet contains: | ||||
Bisoprolol Fumarate | USP | 5mg | antihypertensive agents. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
566 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
Quetiapine Fumarate | IP | |||||
Eq. to quetiapine | 25mg | anti-psychotic drug (atypical type). | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
567 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
Quetiapine Fumarate | IP | |||||
Eq. to quetiapine | 50mg | anti-psychotic drug (atypical type). | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
568 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
Amisulpride | IP | 50mg | antipsychotics | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
569 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
Amisulpride | IP | 100mg | antipsychotics | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
570 | Baclofen Tablet IP | Each Uncoated tablet contains: | ||||
Baclofen | IP | 10mg | skeletal muscle relaxants | |||
Excipients | ||||||
571 | Baclofen Tablet IP | Each Uncoated tablet contains: | ||||
Baclofen | IP | 20mg | skeletal muscle relaxants | |||
Excipients | ||||||
572 | Voglibose Tablet IP | Each Uncoated tablet contains: | ||||
Voglibose | IP | 0.3mg | Alpha glucosidase inhibitors | |||
Excipients | ||||||
573 | Methylcobalamin Tablet | Each Uncoated tablet contains: | ||||
Methylcobalamin | IP | 1500mcg | Alpha glucosidase inhibitors | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
574 | Aciclovir Tablet IP | Each Uncoated tablet contains: | ||||
Aciclovir | IP | 800mg | Anti-viral | |||
Excipients | ||||||
575 | Azathioprine Tablets IP | Each Uncoated tablet contains: | ||||
Azathioprine | IP | 50mg | immunosuppressants | |||
Excipients | ||||||
576 | Acetazolamide Tablet IP | Each Uncoated tablet contains: | ||||
Acetazolamide | IP | 250 mg | carbonic anhydrase inhibitors | |||
Excipients | ||||||
577 | Leflunomide Tablet IP | Each filmcoated tablet contains: | ||||
Leflunomide | IP | 10mg | rheumatoid arthritis | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
578 | Leflunomide Tablet IP | Each filmcoated tablet contains: | ||||
Leflunomide | IP | 20mg | rheumatoid arthritis | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
579 | Gliclazide Tablet IP | Each Uncoated tablet contains: | ||||
Gliclazide | IP | 40mg | antidiabetic | |||
Excipients | ||||||
580 | Gliclazide Tablet IP | Each Uncoated tablet contains: | ||||
Gliclazide | IP | 5mg | antidiabetic | |||
Excipients | ||||||
581 | Digoxin Tablet IP | Each Uncoated tablet contains: | ||||
Digoxin | IP | 0.25mg | cardiac glycosides | |||
Excipients | ||||||
582 | Mebeverine Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Mebeverine Hydrochloride | IP | 135mg | antispasmodic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
583 | Alfuzosin Hydrochloride Tablet | Each filmcoated extended release tablet contain: | alpha blockers | |||
Alfuzosin Hydrochloride | IP | 10mg | ||||
Excipients | ||||||
584 | Oxcarbazepine Tablet IP | Each Uncoated tablet contains: | ||||
Oxcarbazepine | IP | 150mg | anticonvulsants | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
585 | Oxcarbazepine Tablet IP | Each Uncoated tablet contains: | ||||
Oxcarbazepine | IP | 300mg | anticonvulsants | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
586 | Oxcarbazepine Tablet IP | Each Uncoated tablet contains: | ||||
Oxcarbazepine | IP | 600mg | anticonvulsants | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
587 | Clonazepam Tablet IP | Each Uncoated tablet contains: | ||||
Clonazepam | IP | 0.25mg | panic disorder (with or without agoraphobia) | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
588 | Prazosin Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Prazosin Hydrochloride | IP | |||||
Eq. to Prazosin | 1mg | alpha blockers | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
589 | Prazosin Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Prazosin Hydrochloride | IP | |||||
Eq. to Prazosin | 2mg | alpha blockers | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
590 | Aceclofenac Tablet IP | Each Uncoated tablet contains: | ||||
Aceclofenac | IP | 100mg | pain, swelling, inflammation and fever. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
591 | Aceclofenac Tablet IP | Each Uncoated tablet contains: | ||||
Aceclofenac | IP | 200mg | pain, swelling, inflammation and fever. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
592 | Amitriptyline Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Amitriptyline Hydrochloride | IP | 10mg | tricyclic antidepressants. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
593 | Theophylline Prolonged release Tablets IP | Each uncoated prolonged release tablet contains: | ||||
Theophylline Anhydrous | IP | 400mg | xanthines. | |||
Excipients | ||||||
594 | Allopurinol Tablet IP | Each Uncoated tablet contains: | ||||
Allopurinol | IP | 100mg | xanthine oxidase inhibitors | |||
Excipients | ||||||
595 | Doxophylline Tablet IP | Each Uncoated tablet contains: | ||||
Doxophylline | IP | 400mg | asthma. | |||
596 | Chlordiazepoxide Tablet IP | Each filmcoated tablet contains: | ||||
Chlordiazepoxide | IP | 25mg | benzodiazepines. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
597 | Piracetam Tablet | Each filmcoated tablet contains: | ||||
Piracetam | IP | 800mg | synthetic nootropic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
598 | Sumatripta Succinate Tablet | Each filmcoated tablet contains: | ||||
Sumatripta Succinate | IP | |||||
Eq. to Sumatripan | 25mg | serotonin receptor agonists | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
599 | Hydroxyzine Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Hydroxyzine Hydrochloride | IP | 10mg | antihistamines | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
600 | Cinnarlzine Tablet IP | Each Uncoated tablet contains: | ||||
Cinnarlzine | IP | 25mg | antihistamines | |||
Excipients | ||||||
601 | Azathioprine Tablets IP | Each Uncoated tablet contains: | ||||
Azathioprine | IP | 25mg | immunosuppressants | |||
Excipients | ||||||
602 | Topiramine Tablet IP | Each filmcoated tablet contains: | ||||
Topiramine | IP | 25mg | anticonvulsants. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
603 | Lamotrigine Dispersible Tablet IP | Each filmcoated tablet contains: | ||||
Lamotrigine | IP | 50mg | anticonvulsants. | |||
Excipients | ||||||
604 | Lamotrigine Dispersible Tablet IP | Each filmcoated tablet contains: | ||||
Lamotrigine | IP | 50mg | anticonvulsants. | |||
Excipients | ||||||
605 | Lamotrigine Dispersible Tablet IP | Each filmcoated tablet contains: | ||||
Lamotrigine | IP | 100mg | anticonvulsants. | |||
Excipients | ||||||
606 | Methyldopa Tablet IP | Each filmcoated tablet contains: | ||||
Methyldopa | IP | |||||
Eq. to anhydrous Manodopa | 125mg | centrally acting antiadrenergics. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
607 | Methyldopa Tablet IP | Each filmcoated tablet contains: | ||||
Methyldopa | IP | |||||
Eq. to anhydrous Manodopa | 250mg | centrally acting antiadrenergics. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
608 | Esomeprazol Tablet IP | Each enteric coated tablet contain: | ||||
Esomeprazol Magnesium Trihydrates | IP | |||||
Eq. to Esomeprazol | 20mg | proton pump inhibitors | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
609 | Zolpidem Tartrate tablet IP | Each filmcoated tablet contains: | ||||
Zolpidem Tartrate | IP | 10mg | sedative-hypnotics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
610 | Levetiracetam Tablets USP | Each filmcoated tablet contains: | ||||
Levetiracetam | USP | 1000mcg | anticonvulsants. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
612 | Ropinirole Tablet IP | Each filmcoated tablet contains: | ||||
Ropinirole | IP | 1mg | dopamine agonists. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
613 | Ropinirole Tablet IP | Each filmcoated tablet contains: | ||||
Ropinirole | IP | 2mg | dopamine agonists. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
614 | Warfarin Tablet IP | Each filmcoated tablet contains: | ||||
Warfarin Sodium | IP | 5mg | anticoagulants | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
615 | Risperidone Tablet IP | Each uncoated tablet contains: | ||||
Risperidone | IP | 1mg | Atypical antipsychotic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
616 | Risperidone Tablet IP | Each uncoated tablet contains: | ||||
Risperidone | IP | 2mg | Atypical antipsychotic | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
617 | Metoprolol tartrate tablet IP | Each uncoated tablet contains: | ||||
Metoprolol tartrate | IP | 25mg | beta blockers. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
618 | Metoprolol tartrate tablet IP | Each uncoated tablet contains: | ||||
Metoprolol tartrate | IP | 50mg | beta blockers. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
619 | Rizatriptan Tablet IP | Each uncoated tablet contains: | ||||
Rizatriptan Benzoate | IP | |||||
Eq. to rizatriptan | 5mg | selective serotonin receptor agonists. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
620 | Rizatriptan Tablet IP | Each uncoated tablet contains: | ||||
Rizatriptan Benzoate | IP | |||||
Eq. to rizatriptan | 10mg | selective serotonin receptor agonists. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
621 | Mirtazapine Tablet USP | Each filmcoated tablet contains: | ||||
Mirtazapine(Anhydrous) | USP | 7.5mg | antidepressants | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
622 | Mirtazapine Tablet USP | Each filmcoated tablet contains: | ||||
Mirtazapine(Anhydrous) | USP | 15mg | antidepressants | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
623 | Drotaverine HCL tablet IP | Each uncoated tablet contains: | ||||
Drotaverine HCL | 40mg | Anti-inflammtory | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
624 | Drotaverine HCL tablet IP | Each uncoated tablet contains: | ||||
Drotaverine HCL | 80mg | Anti-inflammtory | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
625 | Topiramate Tablet IP | Each filmcoated tablet contains: | ||||
Topiramate | IP | 50Mmg | anticonvulsants or antiepileptic drugs | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
626 | Irbesartan tablet | Each uncoated tablet contains: | ||||
Irbesartan | IP | 150mg | angiotensin receptor blockers | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
627 | Irbesartan tablet | Each uncoated tablet contains: | ||||
Irbesartan | IP | 300mg | angiotensin receptor blockers | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
628 | Glucosamine tablet USP | Each filmcoated tablet contains: | ||||
Glucosamine Sulphate potassium chloride | USP | 500mg | Hexosamines | |||
Eq. to glucosamine | 296mg | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
629 | Pyridostigmine Tablet BP | Each filmcoated tablet contains: | ||||
Pyridostigmine | BP | 60mg | acetylcholinesterase | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
630 | Carbergoline Tablet IP | Each uncoated tablet contains: | ||||
Carbergoline | IP | 0.25mg | dopamine receptor agonists | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
631 | Carbergoline Tablet IP | Each uncoated tablet contains: | ||||
Carbergoline | IP | 0.5mg | dopamine receptor agonists | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
632 | Methotrexate Tablet IP | Each filmcoated tablet contains: | ||||
Methotrexate | IP | 2.5mg | antimetabolites | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
633 | Misoprostol Tablet IP | Each filmcoated tablet contains: | ||||
Misoprostol | IP | 200mcg | a synthetic prostaglandin E1 (PGE1). | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
634 | Aripiprazole Tablet IP | Each uncoated tablet contains: | ||||
Aripiprazole | IP | 20mg | antipsychotics | |||
Excipients | ||||||
635 | Sertraline HCL tablet IP | Each uncoated tablet contains: | ||||
Sertraline HCL | IP | |||||
Eq. to Sertraline | 100mg | antidepressant | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
636 | Flavoxate Tablet | Each uncoated tablet contains: | ||||
Flavoxate HCL | IP | 200mg | antimuscarinics | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
637 | Mirtazapine Tablet USP | Each uncoated tablet contains: | ||||
Mirtazapine | USP | 30mg | antidepressants | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
638 | Deflazacort Tablet | Each uncoated tablet contains: | ||||
Deflazacort | 24mg | corticosteroids. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
639 | Mefloquine Tablet IP | Each uncoated tablet contains: | ||||
Mefloquine hcl | IP | |||||
Eq. to mefloquine Base | 250mg | antimalarials. | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
640 | Carbamazepine Tablet IP | Each uncoated tablet contains: | ||||
Carbamazepine | IP | 200mg | anticonvulsant or anti-epileptic drug. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
641 | Nitrofurantoin Tablet IP | Each uncoated tablet contains: | ||||
Nitrofurantoin | IP | 100mg | antibiotics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
642 | Isosorbide mononitrate Tablet IP | Each uncoated tablet contains: | ||||
Diluted Isosorbide mononitrate | IP | |||||
Eq. to isosorbide mononitrate | 10mg | Nitrate | ||||
Excipients | ||||||
643 | Paroxetine HCL tablet IP | Each uncoated tablet contains: | ||||
Paroxetine HCL | IP | |||||
Eq. to Paroxetine | 20mg | Anti-deperssent | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
644 | Paroxetine HCL tablet IP | Each uncoated tablet contains: | ||||
Paroxetine HCL | IP | |||||
Eq. to Paroxetine | 30mg | Anti-deperssent | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
645 | Citalopram Tablet IP | Each uncoated tablet contains: | ||||
Citalopram Hydrobromide | IP | |||||
Eq. to Citalopram | 10mg | Antidepressant | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
646 | Citalopram Tablet IP | Each uncoated tablet contains: | ||||
Citalopram Hydrobromide | IP | |||||
Eq. to Citalopram | 20mg | Antidepressant | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
647 | Torsemide Tablet IP | Each uncoated tablet contains: | ||||
Torsemide | IP | 5mg | diuretics | |||
Excipients | ||||||
648 | Montelukast Sodium and Fexofenadine Tablet | Each filmcoated tablet contains: | ||||
Montelukast Sodium | IP | |||||
Eq to Montelukast | 10mg | |||||
Fexofenadine hcl | IP | 120mg | leukotriene receptor antagonists | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
649 | Divalproex Sodium Extended release Tablet IP | Each filmcoated tablet contains: | ||||
Divalproex Sodium | IP | |||||
Eq. to Valporic Acid | 250mg | Anticonvulsants | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
650 | Divalproex Sodium Extended release Tablet IP | Each filmcoated tablet contains: | ||||
Divalproex Sodium | IP | |||||
Eq. to Valporic Acid | 500mg | Anticonvulsants | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
651 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
Amisulpride | IP | 50mg | schizophrenia. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
652 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
Amisulpride | IP | 100mg | schizophrenia. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
653 | Amisulpride Tablet IP | Each filmcoated tablet contains: | ||||
Amisulpride | IP | 200mg | schizophrenia. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
654 | Aripiprazole Tablet IP | Each filmcoated tablet contains: | ||||
Aripiprazole | IP | 10mg | antipsychotics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
655 | Aripiprazole Tablet IP | Each filmcoated tablet contains: | ||||
Aripiprazole | IP | 20mg | antipsychotics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
656 | Aripiprazole Tablet IP | Each filmcoated tablet contains: | ||||
Aripiprazole | IP | 15mg | antipsychotics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
657 | Aripiprazole Tablet IP | Each filmcoated tablet contains: | ||||
Aripiprazole | IP | 30mg | antipsychotics. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
658 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
Quetiapine fumarate | IP | |||||
Eq. to Quetiapine | 100mg | schizophrenia | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
659 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
Quetiapine fumarate | IP | |||||
Eq. to Quetiapine | 200mg | schizophrenia | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
660 | Quetiapine Tablet IP | Each filmcoated tablet contains: | ||||
Quetiapine fumarate | IP | |||||
Eq. to Quetiapine | 50mg | schizophrenia | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
661 | Mirtazapine Tablet | Each filmcoated tablet contains: | ||||
Mirtazapine | IP | 7.5mg | antidepressants. | |||
Excipients | ||||||
662 | Mirtazapine Tablet | Each filmcoated tablet contains: | ||||
Mirtazapine | IP | 15mg | antidepressants. | |||
Excipients | ||||||
663 | Sertraline HCL Tablet IP | Each filmcoated tablet contains: | ||||
Sertraline HCL | IP | |||||
Eq. to Sertraline | 25mg | antidepressants | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
664 | Sertraline HCL Tablet IP | Each filmcoated tablet contains: | ||||
Sertraline HCL | IP | |||||
Eq. to Sertraline | 50mg | antidepressants | ||||
Excipients | ||||||
Colour: Approved colour used | ||||||
665 | Fluvoxamine Tablet IP | Each filmcoated tablet contains: | ||||
Fluvoxamine maleate | IP | 50mg | Antidepressant | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
666 | Fluvoxamine Tablet IP | Each filmcoated tablet contains: | ||||
Fluvoxamine maleate | IP | 100 mg | Antidepressant | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
667 | Amitriptyline Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Amitriptyline Hydrochloride | IP | 25mg | antidepressants. | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
667 | Lamotrigine Dispersible Tablet IP | Each uncoated dispersible tablet contains: | anticonvulsants. | |||
Lamotrigine | IP | 50mg | ||||
Excipients | ||||||
668 | Lamotrigine Dispersible Tablet IP | Each uncoated dispersible tablet contains: | ||||
Lamotrigine | IP | 100mg | anticonvulsants. | |||
Excipients | ||||||
669 | Donepezil Hydrochloride Tablet IP | Each filmcoated tablet contains: | ||||
Donepezil Hydrochloride | IP | 5mg | Acetylcholinesterase inhibitor | |||
Excipients | ||||||
Colour: Approved colour used | ||||||
670 | Montelukast Sodium 10mg & Bambuterol Hydrochloride 10 mg tablet | Each uncoated tablet contains: | ||||
Montelukast Sodium Equivalent to | IP | |||||
Montelukast ---------- | 10mg | Anti-allgeric | ||||
Bambuterol Hydrochloride …………. | IP | 10mg | ||||
colour: Ferric Oxide (yellow) | USP-NF | |||||
671 | Minocycline Hydrochloride tablet USP | Composition | ||||
Each filmcoated tablet contains: | ||||||
Minocycline Hydrochloride | USP | Anti-bacterial | ||||
Eq. to minocycline | 50mg | |||||
Excipients | ||||||
Colors: Quinolone yellow lake, sunset yellow FCF & Titanium dioxide | IP | |||||
672 | Minocycline Hydrochloride tablet USP | Composition | ||||
Each filmcoated tablet contains: | ||||||
Minocycline Hydrochloride | USP | |||||
Eq. to minocycline | 100mg | Anti-bacterial | ||||
Excipients | ||||||
Colors: Quinolone yellow lake, sunset yellow FCF & Titanium dioxide | ||||||
673 | Zolpidem tablet IP | Composition | ||||
Each filmcoated tablet contains: | ||||||
Zolpidem Tartrate | IP | 5mg | sedative-hypnotics. | |||
colors: Titanium dioxide & terric oxide (red) | ||||||
674 | Zolpidem tablet IP | Composition | ||||
Each filmcoated tablet contains: | ||||||
Zolpidem Tartrate | IP | 10mg | sedative-hypnotics. | |||
colors: Titanium dioxide & terric oxide (red) | ||||||
675 | Solifenacin Succinate Tablets | Composition | ||||
Each filmcoated tablet contains: | ||||||
Solifenacin Succinate | USP-NF | 5mg | antimuscarinics | |||
Color: ferric oxide ( yellow) Titanium dioxide | IP | |||||
676 | Solifenacin Succinate Tablets | Composition | ||||
Each filmcoated tablet contains: | ||||||
Solifenacin Succinate | USP-NF | 10mg | antimuscarinics | |||
Color: ferric oxide ( yellow) Titanium dioxide | IP | |||||
677 | Alfuzosin Prolonged release tablet IP 10 mg | Composition | ||||
Each filmcoated tablet contains: | ||||||
Alfuzosin Hydrochloride | IP | 10mg | alpha blockers. | |||
colors: Titanium dioxide | IP | |||||
678 | Trbinafine 250mg tablet USP | Composition | ||||
Each filmcoated tablet contains: | ||||||
Trbinafine Hydrochloride | USP | 250mg | antifungal | |||
Eq.to trbinafine | ||||||
679 | Nimesulide 100mg & Paracetamol 325mg tablets | Composition | ||||
Each filmcoated tablet contains: | ||||||
Nimesulide | BP | 100mg | Nimesulide (NSAID) and Paracetamol (Antipyretic) | |||
Paracetamol | IP | 325mg | ||||
Excipients | ||||||
680 | Piroxicam Tablets 20mg | Each dispersible tablet contains: | ||||
Piroxicam USP | 20mg | NSAIDs | ||||
Excipients | ||||||
681 | Nimesulide and Paracetamol tablet | Each uncoated tablet contains: | ||||
Nimesulide | BP | 100mg | ||||
Paracetamol | IP | 325mg | Nimesulide (NSAID) and Paracetamol (Antipyretic) | |||
Excipients | ||||||
682 | Solifenacin Succinate Tablets | Composition | ||||
Each filmcoated tablet contains: | USP-NF | 10mg | antimuscarinics | |||
Solifenacin Succinate | IP | |||||
Color: ferric oxide ( yellow) | ||||||
683 | Alfuzosin Prolonged release tablet IP 10 mg | Composition | ||||
Each filmcoated tablet contains: | ||||||
Alfuzosin Hydrochloride | USP | 10mg | alpha blockers | |||
Colour: Titanium dioxide | IP | |||||
684 | Trbinafine 250mg tablet USP | Composition | ||||
Each filmcoated tablet contains: | ||||||
Trbinafine Hydrochloride | USP | 250mg | Anti-fungal | |||
Eq. to Trbinafine | ||||||
685 | Nimesulide 100mg &Paracetamol 325mg tablets | Composition | ||||
Each filmcoated tablet contains: | ||||||
Nimesulide | 100mg | |||||
Paracetamol | 325mg | Nimesulide (NSAID) and Paracetamol (Antipyretic) | ||||
Excipients | ||||||
686 | Rantidine Tablet | Each filmcoated tablet contains: | ||||
Rantidine | IP | 150mg | H2 blockers. | |||
Excipients | q.s | |||||
Colour: Ferric oxide (red) | ||||||
687 | Acetaminophen and Diclofenac Potassium Tablet | Each filmcoated tablet contains: | ||||
Acetaminophen | IP | 500mg | ||||
Diclofenac Potassium | IP | 50mg | anti-inflammatory drug (NSAID). | |||
Excipients | ||||||
colour: Sunset yellow | ||||||
688 | Ofloxacin with Ornidazole Tablet | Each filmcoated tablet contains: | ||||
Ofloxacin | IP | 200mg | quinolone antibiotics. | |||
Ornidazole | IP | 500mg | ||||
Excipients | ||||||
colour: Titanium dioxide | ||||||
689 | Norfloxacin& Metronidazole Tablets | Each filmcoated tablet contains: | ||||
Norfloxacin | IP | 500mg | quinolone antibiotics | |||
Metronidazole | IP | 400mg | ||||
colour: Ponceau 4R | ||||||
690 | Ciprofloxacin tablets | Each filmcoated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | 250mg | Anti-bacterial | |||
Eq. to Ciprofloxacin | ||||||
Excipients | ||||||
colour: Titanium dioxide | ||||||
691 | Ciprofloxacin tablets | Each filmcoated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | 500mg | Anti-bacterial | |||
Eq. to Ciprofloxacin | ||||||
Excipients | ||||||
colour: Titanium dioxide | ||||||
692 | Ofloxacine Tablet | Each filmcoated tablet contains: | ||||
Ofloxacine | IP | 400mg | antibiotics | |||
Excipients | ||||||
colour: Titanium dioxide | ||||||
693 | Diclofenac with Paracetamol Tablet | Each filmcoated tablet contains: | ||||
Diclofenac sodium | IP | 100mg | ||||
Paracetamol | IP | 325mg | Anti-inflammtory | |||
Excipients | ||||||
colour: Titanium dioxide | ||||||
694 | Deflazacort 6 Tablet | Each uncoated tablet contains: | ||||
Deflazacort | IP | 6mg | corticosteroids. | |||
Excipients | ||||||
695 | Deflazacort 6 Tablet | Each uncoated tablet contains: | ||||
Deflazacort | IP | 12mg | corticosteroids. | |||
Excipients | ||||||
696 | Terbinafine 250 Tablet | Each uncoated tablet contains: | ||||
Terbinafine Hydrochloride | USP | 250mg | Anti-fungal | |||
Excipients | ||||||
697 | Terbinafine 250 Tablet | Each uncoated tablet contains: | ||||
Terbinafine Hydrochloride | USP | 500mg | Anti-fungal | |||
Excipients | ||||||
698 | Levocetirizine and fexofinadine Tablet | Each filmcoated tablet contains: | ||||
Levocetirizine Hydrochloride | IP | 2.5mg | antihistamines | |||
fexofinadine Hydrochloride | IP | 120mg | ||||
colour: Titanium dioxide | ||||||
700 | Fluconazole tablet | Each uncoated tablet contains: | ||||
Fluconazole | IP | 150mg | Anti-fungal | |||
Excipients | ||||||
701 | Cefprozil Tablet | Each filmcoated tablet contains: | ||||
Cefprozil | IP | 250mg | cephalosporin antibiotics. | |||
colour: Titanium dioxide | ||||||
702 | Cefprozil Tablet | Each filmcoated tablet contains: | ||||
Cefprozil | IP | 500mg | cephalosporin antibiotics. | |||
colour: Titanium dioxide | ||||||
703 | Diclofenac with Paracetamol Tablet | Each uncoated tablet contains: | ||||
Diclofenac | IP | 50mg | ||||
Paracetamol | IP | 325mg | Anti-inflammatory | |||
Excipients | ||||||
704 | Sidenafil Citrate Tablet | Each filmcoated tablet contains: | ||||
Sidenafil Citrate | IP | 50mg | phosphodiesterase (PDE) inhibitors | |||
Excipients | ||||||
colour: Titanium dioxide | ||||||
705 | Sidenafil Citrate Tablet | Each filmcoated tablet contains: | ||||
Sidenafil Citrate | IP | 10mg | phosphodiesterase (PDE) inhibitors | |||
Excipients | ||||||
colour: Titanium dioxide | ||||||
706 | Riboflavin,folic acid Niacinamide& Lactic acid Bacillus spores Tablet | Each uncoated tablet contains: | ||||
Riboflavin | IP | 10mg | vitamin | |||
folic acid | IP | 1.5mg | ||||
Niacinamide | IP | 100mg | ||||
Lactic acid Bacillus | IP | 60million spores | ||||
Excipients | q.s | |||||
707 | Zinc sulphate Tablet BP 50mg | Each filmcoated tablet contains: | ||||
Zinc sulphate Monohydrate 137.232mg | IP | |||||
Eq. to Elemental Zinc | 50mg | Zinc deficiency | ||||
Excipients | ||||||
colour Titanium Dioxide IP | ||||||
708 | Cefuroxime Axetil tablet BP 500mg (for export) | Each filmcoated tablet contains: | ||||
Cefuroxime Axetil | BP | |||||
Eq. to Cefuroxime | 500mg | cephalosporin antibiotics | ||||
Excipients | q.s | |||||
Colour: Approved colour used | ||||||
709 | Sildosin 4mg & Dutasteride 0.5mg Tablets | Each Film Coated Tablet Contains: | ||||
Sildosin | 4mg | |||||
Dutastreride | IP | 0.5mg | ||||
Excipients | q.s | |||||
Colour quinoline Yellows ws | ||||||
710 | Sildosin 8mg &Dutasteride 0.5mg Tablets | Each Film Coated Tablet Contains: | ||||
Sildosin | 8mg | |||||
Dutastreride | IP | 0.5mg | ||||
Excipients | q.s | |||||
Colour:Lake Sunset yellow | ||||||
711 | Acebrophylline Sustained release | Each Film Coated Sustained release Tablet Contains: | ||||
tablet 200mg | Acebrophylline | IP | 200mg | |||
Excipients | q.s | |||||
Colour: Approved colour used | ||||||
712 | Tapentadol Tablet 50mg | Each Film Coated Tablet Contains: | ||||
Tapentadol Hydrochloride | IP | 50mg | ||||
Eq.to Tapentadol | q.s | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
714 | Tapentadol Tablet 100mg | Each Film Coated Tablet Contains: | ||||
Tapentadol Hydrochloride | IP | 100mg | ||||
Eq.to Tapentadol | q.s | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
715 | Tapentadol Tablet 200mg | Each Film Coated Tablet Contains: | ||||
Tapentadol Hydrochloride | IP | 200mg | ||||
Eq.to Tapentadol | q.s | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
716 | Azithromycin Tablets IP | Each Film Coated Tablet Contains: | ||||
Azithromycin (As Dihydrate) | IP | 250mg | ||||
Eq.to Anhydrous | ||||||
Azithromycin | ||||||
Excipients | ||||||
Coloue: Yellow Oxide Of Iron | ||||||
717 | Azithromycin Tablets IP | Each Film Coated Tablet Contains: | ||||
Azithromycin (As Dihydrate) | IP | 500mg | ||||
Eq.to Anhydrous | ||||||
Azithromycin | ||||||
Excipients | ||||||
Coloue: Yellow Oxide Of Iron | ||||||
718 | Paracetamol, Phenylephrine Hydrochloride | Each uncoated Tablet Contains: | ||||
&Chlopheniramine Maleate Tablets | Paracetamol | IP | 500mg | |||
Phenylephrine HCl. | IP | 10mg | ||||
Chlorpheniramine Maleate | IP | 2mg | ||||
719 | Amoxycillin Dispersible Tablet IP | Each Uncoated dispersible tablet Contains: | ||||
Amoxycillin Trihydrate | IP | 250mg | ||||
Eq.to Amoxycillin | Q.S | |||||
Excipients | ||||||
Colour: Approved colour used | ||||||
720 | Acecolofenac, Paracetamol,Cetirizine Dihydrochloride, Phenylephrine Hydrochloride & Caffeine Tablets | Each uncoated bilayered tablet contains: | ||||
Aceclofenac | IP | 100mg | ||||
Paracetamol | IP | 325mg | ||||
Phenylephrine HCl. | IP | 5mg | ||||
Cetirizine Dihydrochloride | IP | 10mg | ||||
Caffeine Anhydrous | IP | 25mg | ||||
Excipients | q.s | |||||
721 | Sildenafil Citrate tablets IP 100mg | Each Film coated tablet Contains: | ||||
Sildenafil Citrate | IP | 100mg | ||||
Eq.to Sildenafil | q.s | |||||
Excipients | ||||||
Coloue: Red oxide of oron,Lake of Indigo | ||||||
722 | Diclofenac Potassium, Paracetamol &Serratiopeptidase Tablets | Each Film Coated tablet Contains: | ||||
Diclofenac Potassium | BP | 50mg | ||||
Paracetamol | IP | 325mg | ||||
Serratiopeptidase | IP | 15mg | ||||
(As 30,000 Enzymatic units of Serratiopeptidase) | q.s | |||||
Excipients | ||||||
Colour: Sunset Yellow | ||||||
723 | Paracetamol, Levocetirizine Hydrochloride ,Dextromethorphan Hydrobromide,Phenylephrine Hydrochloride & Caffeine Tablets | Each uncoated Tablet Contains: | ||||
Paracetamol | IP | 325mg | ||||
Levocetirizine Hydrochloride | IP | 5mg | ||||
Dextromethorphan Hydrobromide | IP | 5mg | ||||
Phenylephrine Hydrochloride | IP | 5mg | ||||
Caffeine Anhydrous | IP | 30mg | ||||
Excipients | q.s | |||||
Approved colour used | ||||||
724 | Nimesulide, Paracetamol & Serratiopeptidase tablets | Each Film coated tablet Contains: | ||||
Nimesulide | BP | 100mg | ||||
Paracetamol | IP | 325mg | ||||
Serratiopeptidase (Enteric coated) | IP | 15mg | ||||
(As 30,000 Enzymatic units of Serratiopeptidase) | q.s | |||||
Excipients | ||||||
Approved colour used | ||||||
725 | nimesulide, Phenylephrine Hydrochloride,Cetirizine dihydrochloride &Caffeine tablets | Each Film coated tablet Contains: | ||||
Nimesulide | BP | 100mg | ||||
Phenylephrine Hydrochloride | IP | 10mg | ||||
Cetrizine dihydrochloride | IP | 5mg | ||||
Caffeine Anhydrous | IP | 30mg | ||||
Excipients | q.s | |||||
Approved colour used | ||||||
726 | Aceclofenac,Paracetamol,Cetirizine,Phenylephrine Hydrochloide & CaffeineTablets | Each uncoated Tablet Contains: | ||||
Aceclofenac | IP | 100mg | ||||
Paracetamol | IP | 325mg | ||||
Cetirizine Dihydrochloride | IP | 10mg | ||||
Phenylephrine Hydrochloride | IP | 5mg | ||||
Caffeine Anhydrous | IP | 25mg | ||||
Excipients | q.s | |||||
Approved colour used | ||||||
727 | Paracetamol Levocetirizine Hydrochloride & | Each Film Coated Tablet Contains: | ||||
Phenylephrine Hydrochloride Tablets | Paracetamol | IP | 325mg | |||
Cetrizine dihydrochloride | IP | 5mg | ||||
Phenylephrine Hydrochloride | IP | 10mg | ||||
Caffeine Anhydrous | IP | 30mg | ||||
Excipients | Q.S | |||||
Approved colour used | ||||||
728 | Paracetamol,Phenylephrine Hydrochloride,Chlorpheniramine Maleate&Caffeine Tablets | Each Film coated tablet Contains: | ||||
Paracetamol | IP | 325mg | ||||
Phenylephrine Hydrochloride | IP | 10mg | ||||
Chlorpheniramine Maleate | IP | 2mg | ||||
Caffeine Anhydrous | IP | 30mg | ||||
Excipients | Q.S | |||||
Approved colour used | ||||||
727 | Paracetamol , Phenylephrine Hydrochloride,Caffeine & Diphenhydramine Hydrochloride Tablets | Each uncoated Tablet Contains: | ||||
Paracetamol | IP | 500mg | ||||
Phenylephrine Hydrochloride | IP | 5mg | ||||
Caffeine Anhydrous | IP | 30mg | ||||
Diphenhydramine hydrochoride | IP | 25mg | ||||
Excipients | Q.S | |||||
Approved colour used | ||||||
728 | Tranexamic Acid & Mefenamic Acid Tablets | Each Film coated tablet Contains: | ||||
Tranexamic Acid | IP | 500mg | ||||
Mefenamic Acid | IP | 250mg | ||||
Excipients | Q.S | |||||
Approved colour used | ||||||
729 | Nimesulide,Phenylephrine hydrochloride, Levocetrizine Dihydrochloride Tablets | Each uncoated Tablet Contains: | ||||
Nimesulide | BP | 100mg | ||||
Phenylephrine Hydrochloride | IP | 5mg | ||||
Levocetirizine dihydrochloride | IP | 5mg | ||||
Excipients | Q.S | |||||
Approved colour used | ||||||
730 | Paracetamol, Phenylephrine Hydrochloride,Guaiphenesin | Each uncoated Tablet Contains: | ||||
Cetirizine Dihydrochloride & Ambroxol HCl.Tablets | Paracetamol | IP | 325mg | |||
Phenylephrine Hydrochloride | IP | 5mg | ||||
Guaiphensin | IP | 50mg | ||||
Cetrizine dihydrochloride | IP | 5mg | ||||
Ambroxol Hydrochloride | IP | 15mg | ||||
Excipients | Q.S | |||||
Approved colour used | ||||||
731 | Glimepiride,pioglitazone & Metformin Hydrochloride Tablets | Each uncoated Tablet Contains: | ||||
Glimepiride | IP | 1mg | ||||
Pioglitazone HCl. | IP | 15mg | ||||
Eq.to Pioglitazone | IP | 500mg | ||||
Metformin Hydrochloride | Q.S | |||||
Excipients | ||||||
Approved colour used | ||||||
732 | Glimepiride,pioglitazone & Metformin Hydrochloride Tablets | Each uncoated Tablet Contains: | ||||
Glimepiride | IP | 2mg | ||||
Pioglitazone HCl. | IP | 15mg | ||||
Eq.to Pioglitazone | IP | 500mg | ||||
Metformin Hydrochloride | Q.S | |||||
Excipients | ||||||
Approved colour used | ||||||
733 | Cefixime Dispersible Tablets | Each uncoated Dispersible Tablet Contains: | ||||
Cefixime Trihydrate | IP | 200mg | ||||
Eq.to Anhydrous Cefixime | Q.S | |||||
Excipients | ||||||
Approved colour used | ||||||
734 | Cefixime & Lactic acid Bacillus Dispersible Tablets | Each uncoated Dispersible Tablet Contains: | ||||
Cefixime Trihydrate | IP | 200mg | ||||
Eq.to Anhydrous Cefixime | ||||||
Lactic acid Bacillus 60million spores | Q.S | |||||
Excipients | ||||||
Approved colour used | ||||||
735 | Diclofenac sodium, Paracetamol & Serratiopeptidase | Composition | ||||
Each Film coated tablets Contains: | ||||||
Diclofenac sodium | BP | 50mg | ||||
Paracetamol | IP | 325mg | ||||
Serratiopeptidase | IP | 10mg | ||||
(As 20,000 Enzymatic units of Serratiopeptidase) | q.s | |||||
Excipients | ||||||
Approved colour used | ||||||
736 | Montelukast Sodium & | Each Film coated tablet Contains: | ||||
Levocetrizine Hydrochloride | Montelukast Sodium | IP | 10mg | |||
tablets IP | Eq.to Montelukast | IP | 5mg | |||
Levocetrizine Hydrochloride | Q.S | |||||
Excipients | ||||||
colour: Titanium dioxide IP | ||||||
737 | Acebrophylline & Acetylcysteine | Each film coated bilayered tablet | ||||
Tablets | Contains: | 100mg | ||||
Acebrophylline | BP | 600mg | ||||
Acetylcysteine | Q.S | |||||
Excipients | ||||||
738 | N-Acetylcysteine Tablets 600mg | Each Uncoated tablet contains: | ||||
N-Acetylcysteine | BP | 600mg | ||||
Excipients | Q.S | |||||
739 | Levocetirizine HCl.,Montelukast | Each uncoated bilayered tablet | ||||
& Ambroxol HCl Tablet | contains: | 5mg | ||||
Levocetrizine Hydrochloride | 10mg | |||||
Montelukast Sodium | 75mg | |||||
Eq.to Montelukast | ||||||
Ambroxol Hydrochloride | q.s | |||||
(As Sustained release) | ||||||
Excipients | ||||||
Approved colour used | IP | |||||
IP | ||||||
IP | ||||||
Enquiry